var title_f23_41_24208="Parotid enlarge SS";
var content_f23_41_24208=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F69831&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F69831&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Parotid gland enlargement in Sj&ouml;gren's syndrome on magnetic resonance imaging",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 244px; height: 356px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Sj&ouml;gren's syndrome can lead to massive salivary gland enlargement,&nbsp;which is shown here&nbsp;on magnetic resonance imaging (MRI). MRI studies should be performed with gadolinium and with \"fat subtraction\" to permit evaluation of the ductal system.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert Fox, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_41_24208=[""].join("\n");
var outline_f23_41_24208=null;
var title_f23_41_24209="Balanoposthitis algorithm";
var content_f23_41_24209=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F76384&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F76384&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 562px\">",
"   <div class=\"ttl\">",
"    Evaluation algorithm for balanoposthitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 542px; height: 638px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Patients with refractory balanoposthitis, recurrence, or scarring with phimosis warrant referral to a pediatric urologist.",
"    <div class=\"footnotes\">",
"     Rx: treatment; STD: sexually transmitted disease.",
"     <br>",
"      * Presumptive treatment without specific testing for infectious pathogens is appropriate in young boys (&lt;6 years of age).",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_41_24209=[""].join("\n");
var outline_f23_41_24209=null;
var title_f23_41_24210="Normal shoulder ligaments";
var content_f23_41_24210=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F62016&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F62016&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 559px\">",
"   <div class=\"ttl\">",
"    Normal shoulder ligaments",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 539px; height: 408px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_41_24210=[""].join("\n");
var outline_f23_41_24210=null;
var title_f23_41_24211="Artificial tears: Drug information";
var content_f23_41_24211=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Artificial tears: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?3/31/3572?source=see_link\">",
"    see \"Artificial tears: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/15/38131?source=see_link\">",
"    see \"Artificial tears: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F136850\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Advanced Eye Relief&trade; Dry Eye Environmental [OTC];",
"     </li>",
"     <li>",
"      Advanced Eye Relief&trade; Dry Eye Rejuvenation  [OTC];",
"     </li>",
"     <li>",
"      Bion&reg; Tears [OTC];",
"     </li>",
"     <li>",
"      HypoTears [OTC];",
"     </li>",
"     <li>",
"      Murine Tears&reg; [OTC];",
"     </li>",
"     <li>",
"      Soothe&reg; Hydration [OTC];",
"     </li>",
"     <li>",
"      Soothe&reg; [OTC];",
"     </li>",
"     <li>",
"      Systane&reg; Ultra [OTC];",
"     </li>",
"     <li>",
"      Systane&reg; [OTC];",
"     </li>",
"     <li>",
"      Tears Again&reg; [OTC];",
"     </li>",
"     <li>",
"      Tears Naturale&reg; Forte [OTC];",
"     </li>",
"     <li>",
"      Tears Naturale&reg; Free [OTC];",
"     </li>",
"     <li>",
"      Tears Naturale&reg; II [OTC];",
"     </li>",
"     <li>",
"      Viva-Drops&reg; [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F136851\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Teardrops&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F136859\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Ophthalmic Agent, Miscellaneous",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F136852\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Ocular dryness/irritation:",
"     </b>",
"     Ophthalmic: 1-2 drops into eye(s) as needed to relieve symptoms",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F136856\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/15/38131?source=see_link\">",
"      see \"Artificial tears: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F136853\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F136845\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Solution, ophthalmic:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Advanced Eye Relief&trade; Dry Eye Environmental: Glycerin 1% (15 mL) [contains benzalkonium chloride]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Advanced Eye Relief&trade; Dry Eye Rejuvenation: Glycerin 0.3% and propylene glycol 1% (30 mL) [contains benzalkonium chloride]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     HypoTears: Polyvinyl alcohol 1% and polyethylene glycol 400 1% (30 mL) [contains benzalkonium chloride]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Murine Tears&reg;: Polyvinyl alcohol 0.5% and povidone 0.6% (15 mL) [contains benzalkonium chloride]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Soothe&reg; Hydration: Povidone 1.25% (15 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Systane&reg; Ultra: Polyethylene glycol 400 0.4% and propylene glycol 0.3% (5 mL, 10 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Systane&reg;: Polyethylene glycol 400 0.4% and propylene glycol 0.3% (5 mL, 15 mL, 30 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Tears Again&reg;: Polyvinyl alcohol 1.4% (30 mL) [contains benzalkonium chloride]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Tears Naturale&reg; II: Dextran 70 0.1% and hydroxypropyl methylcellulose 2910 0.3% (30 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Tears Naturale&reg; Forte: Dextran 70 1%, glycerin 0.2%, and hydroxypropyl methylcellulose  2910 0.3% (30 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Solution, ophthalmic [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Bion&reg; Tears: Dextran 70 0.1% and hydroxypropyl methylcellulose 2910 0.3% per 0.4 mL (28s)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Soothe&reg;: Glycerin 0.6% and propylene glycol 0.6% per 0.6 mL (28s)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Systane&reg; Ultra: Polyethylene glycol 400 0.4% and propylene glycol 0.3% per 0.4 mL (24s)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Tears Naturale&reg; Free: Dextran 70 0.1% and hydroxypropyl methylcellulose 2910 0.3% per 0.5 mL (36s, 60s)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Viva-Drops&reg;: Polysorbate 80 1% (0.5 mL, 10 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F136834\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F136846\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Ophthalmic lubricant; for temporary relief of burning and eye irritation due to dry eyes",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F136862\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Isopto&reg; Tears may be confused with Isoptin&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F136857\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined: Ocular: blurred vision, crusting of eyelids, mild stinging",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F136837\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Contact lens wearers: Ophthalmic solutions may contain benzalkonium chloride which may be absorbed by contact lenses. Remove contact lenses before using.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Preservative free formulations: Preservative free formulations are preferred in patients with severe dry eye or patients on multiple eye drops for chronic disease. Once opened, single use containers should be discarded; do not reuse.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Self-medication (OTC use): When used for self-medication (OTC), stop use and contact healthcare provider if changes in vision, eye pain, continued redness or irritation occur, or if the condition worsens or persists for more than 72 hours. To avoid contamination, do not touch tip of container to any surface. Replace cap after using. Do not use if solution is cloudy or changes color.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298775\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6218082\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323001\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Ointment",
"     </b>",
"     (Tears Naturale PM Ophthalmic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     3-94% (3.5 g): $8.39",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Akwa Tears Ophthalmic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1.4% (15 mL): $5.56",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Akwa Tears Renewed Ophthalmic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.1-0.3% (15 mL): $6.18",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (HypoTears Ophthalmic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1-1% (15 mL): $9.54",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Refresh Optive Advanced Ophthalmic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.5-1-0.5% (10 mL): $11.36",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Tears Naturale Forte Ophthalmic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.1-0.2-0.3% (15 mL): $10.02",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Tears Naturale Free Ophthalmic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.1-0.3% (36): $10.38",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F136848\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Teardrops (CA)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F13273115\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Products contain demulcents (ie, cellulose derivatives, dextran 70, gelatin, polyols, polyvinal alcohol, or povidone); usually a water-soluble polymer, applied topically to the eye to protect and lubricate mucous membrane surfaces and relieve dryness and irritation",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Calonge M, \"The Treatment of Dry Eye,\"",
"      <i>",
"       Surv Ophthalmol",
"      </i>",
"      , 2001, 45(Suppl 2):227-39.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24211/abstract-text/11587147/pubmed\" id=\"11587147\" target=\"_blank\">",
"        11587147",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      \"Management and Therapy of Dry Eye Disease: Report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007),\"",
"      <i>",
"       Ocul Surf",
"      </i>",
"      ,  2007, 5(2):163-78.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24211/abstract-text/17508120/pubmed\" id=\"17508120\" target=\"_blank\">",
"        17508120",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8660 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-42E0F5FCD1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_41_24211=[""].join("\n");
var outline_f23_41_24211=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136850\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136851\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136859\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136852\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136856\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136853\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136845\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136834\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136846\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136862\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136857\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136837\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298775\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6218082\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16323001\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136848\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13273115\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8660\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8660|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?3/31/3572?source=related_link\">",
"      Artificial tears: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/15/38131?source=related_link\">",
"      Artificial tears: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_41_24212="Methoxsalen (systemic): Patient drug information";
var content_f23_41_24212=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Methoxsalen (systemic): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/59/37813?source=see_link\">",
"     see \"Methoxsalen (systemic): Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F8770721\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      8-MOP&reg;;",
"     </li>",
"     <li>",
"      Oxsoralen-Ultra&reg;;",
"     </li>",
"     <li>",
"      Uvadex&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F8770722\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Oxsoralen-Ultra&reg;;",
"     </li>",
"     <li>",
"      Oxsoralen&reg; Capsule;",
"     </li>",
"     <li>",
"      Ultramop&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10024370\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700508",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad burns may happen if this drug is not used the right way. Follow what your doctor told you to do closely.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700566",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is more than 1 brand of this drug. One brand cannot safely be used for the other. Your doctor will tell you about any needed change.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10024372\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692188",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat white patches on your skin (vitiligo).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat psoriasis.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat skin cancer.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10024371\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702500",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to methoxsalen or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703689",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Melanoma or squamous cell cancer.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703878",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you sunburn easily.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10024376\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697781",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear sunglasses during and for 24 hours after care. Protect lips with lipstick that has sunscreen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696812",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not go over the time you are told to use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696953",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sun or UV rays may age the skin and raise the chance of skin cancer.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10024377\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698359",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sunburn.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698191",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Itching.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10024379\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10024374\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695824",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take 2 hours before being exposed to UV light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695907",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug with food.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694536",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid eating foods such as carrots, celery, cloves, figs, lemons, limes, mustard, or parsley.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10024375\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696446",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor to find out what to do.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10024380\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10024381\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12246 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-201.65.114.212-C0B5FDA9AB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_41_24212=[""].join("\n");
var outline_f23_41_24212=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8770721\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8770722\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024370\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024372\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024371\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024376\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024377\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024379\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024374\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024375\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024380\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024381\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?36/59/37813?source=related_link\">",
"      Methoxsalen (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?21/19/21811?source=related_link\">",
"      Methoxsalen (topical): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?2/5/2132?source=related_link\">",
"      Methoxsalen (topical): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_41_24213="Osteoarthritis of the elbow";
var content_f23_41_24213=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F77197%7EEM%2F63975&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F77197%7EEM%2F63975&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Osteoarthritis of the elbow",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 472px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Severe joint space narrowing and sclerosis of the articular bone surfaces (arrow) is evident.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Bruce C Anderson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Post traumatic arthritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 464px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This patient sustained an elbow fracture in the past. Osteoarthritis is now manifest by severe narrowing of the joint space, sclerosis (black arrow), and osteophytes (white arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Bruce C Anderson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_41_24213=[""].join("\n");
var outline_f23_41_24213=null;
var title_f23_41_24214="Urine sampling and culture in the diagnosis of urinary tract infection in adults";
var content_f23_41_24214=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Urine sampling and culture in the diagnosis of urinary tract infection in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/41/24214/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/41/24214/contributors\">",
"     Alain Meyrier, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/41/24214/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/41/24214/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/41/24214/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/41/24214/contributors\">",
"     Allyson Bloom, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/41/24214/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 17, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urine collected in a normal individual by suprapubic aspiration of the bladder is sterile and does not contain leukocytes. This method represents the gold standard in the diagnosis of urinary tract infection (UTI) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24214/abstract/1\">",
"     1",
"    </a>",
"    ]. It is, however, not performed routinely in clinical practice in which urine samples are generally obtained after natural micturition; in this setting, some degree of artifactual contamination with normal urethral organisms must be accepted.",
"   </p>",
"   <p>",
"    Among patients with symptoms suggestive of a UTI (dysuria and frequency), the diagnosis can be confirmed by sending a clean-catch specimen for culture and for urinalysis. One suggested exception recommended by most experts is a symptomatic young woman with pyuria (detected by urinalysis or dipstick) who has apparently uncomplicated cystitis. It has been proposed that this constellation of findings is sufficiently diagnostic that an empiric course (usually three days) of antimicrobial therapy can be initiated without performing a urine culture [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24214/abstract/2\">",
"     2",
"    </a>",
"    ]. The choice of antibiotic is generally determined by the local susceptibility patterns of Escherichia coli, the usual causative organism, and a patient history of antibiotic allergy, especially to sulfonamides. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/15/13561?source=see_link&amp;anchor=H899949198#H899949198\">",
"     \"Acute uncomplicated cystitis and pyelonephritis in women\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The indications for culture in young women are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Suspicion of a complicated infection",
"     </li>",
"     <li>",
"      Atypical symptoms",
"     </li>",
"     <li>",
"      Failure to respond to initial therapy, raising the possibility of a resistant organism",
"     </li>",
"     <li>",
"      Recurrent symptoms less than one month after treatment of a previous UTI for which no culture was performed (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/15/13561?source=see_link\">",
"       \"Acute uncomplicated cystitis and pyelonephritis in women\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/47/10999?source=see_link\">",
"       \"Acute complicated cystitis and pyelonephritis\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     URINE SAMPLING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The likelihood of detecting a UTI by urine culture is highest if urine is collected on arising. This sample is likely to be most concentrated and bacteria in the bladder will have had time to multiply overnight. However, this ideal sample is not practical since most cultures are obtained at the time the patient is seeing the clinician. In this setting, the combination of a more dilute urine and partial bacterial washout due to multiple voids may lower the colony count below the accepted definition for a UTI (see below).",
"   </p>",
"   <p>",
"    The following steps should be performed to minimize the degree of bacterial contamination.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Local disinfection of the meatus and adjacent mucosa should be performed with a nonfoaming antiseptic solution; this region should then be dried with a sterile swab to avoid mixture of the antiseptic with urine.",
"     </li>",
"     <li>",
"      Contact of the urinary stream with the mucosa should be minimized by spreading the labia in females and by pulling back the foreskin in uncircumcised males.",
"     </li>",
"     <li>",
"      The first voided specimen should be discarded since the initial urine flushes urethral contaminants. It is the second, midstream sample that should be sent to the laboratory.",
"     </li>",
"     <li>",
"      Evaluation of the last few drops of urine is indicated after prostatic massage in men with suspected prostatitis. Firm prostatic massage per rectum, from lateral to midline on each side, causes the contents of the prostatic ducts to be expressed; vertical strokes in the midline will then project the secretions into the urethra and permit counting of leukocytes. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/60/23496?source=see_link&amp;anchor=H14689268#H14689268\">",
"       \"Chronic bacterial prostatitis\", section on 'Obtaining and testing prostatic specimens'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The urine sample should be sent immediately to the bacteriology laboratory since bacteria will continue to proliferate in the warm medium of freshly voided urine, leading to increased bacterial counts. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/15/35059?source=see_link\">",
"     \"Microbiology specimen collection and transport\"",
"    </a>",
"    .) If such immediate referral is not possible, the container should be transported in iced water and then stored in a refrigerator at 4&ordm;C. Cooling stops bacterial growth, but the following day the bacteria can still grow on culture medium. However, urinary leukocytes may be altered by refrigeration, possibly affecting interpretation of the urinalysis.",
"   </p>",
"   <p>",
"    Urine sampling techniques in young children are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/56/42886?source=see_link\">",
"     \"Urine collection techniques in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DEFINITION OF A POSITIVE CULTURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The standard definition of a positive urine culture is &ge;10",
"    <sup>",
"     5",
"    </sup>",
"    <span class=\"nowrap\">",
"     CFU/mL",
"    </span>",
"    together with pyuria (eg, leukocyte count &ge;10",
"    <sup>",
"     5",
"    </sup>",
"    <span class=\"nowrap\">",
"     WBC/mL).",
"    </span>",
"    Normal values in a noninfected midstream, clean-catch sample are &lt;10",
"    <sup>",
"     5",
"    </sup>",
"    colony-forming units (CFU, primarily due to contaminating Escherichia coli) and &lt;10,000 leukocytes per mL of urine [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24214/abstract/3-7\">",
"     3-7",
"    </a>",
"    ]. Contamination in the absence of UTI is typically suggested by high CFU counts without significant leukocyturia in a patient with no urinary tract symptoms such dysuria, frequency or fever.",
"   </p>",
"   <p>",
"    However, this definition does not apply to all patients. If fecal contamination has been ruled out, a lower colony count",
"    <span class=\"nowrap\">",
"     (&gt;10",
"     <sup>",
"      2",
"     </sup>",
"     /mL)",
"    </span>",
"    may be indicative of UTI. This was best demonstrated in studies in women who had dysuria and frequency but a midstream culture contained less 10",
"    <sup>",
"     5",
"    </sup>",
"    <span class=\"nowrap\">",
"     CFU/mL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24214/abstract/1,8,9\">",
"     1,8,9",
"    </a>",
"    ]. This condition had been called the acute urethral syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24214/abstract/1\">",
"     1",
"    </a>",
"    ]. In one study, for example, 42 such women (most of whom had &ge;10",
"    <sup>",
"     2",
"    </sup>",
"    <span class=\"nowrap\">",
"     CFU/mL",
"    </span>",
"    on culture of a midstream specimen) who also had pyuria underwent suprapubic bladder aspiration. Thirty seven had a positive aspirate culture: 24 E. coli, 3 Staphylococcus saprophyticus, and 10 Chlamydia [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24214/abstract/1\">",
"     1",
"    </a>",
"    ]. All of these women responded to appropriate antimicrobial therapy. In comparison, a positive culture was very uncommon in women with similar symptoms but no pyuria.",
"   </p>",
"   <p>",
"    Similar findings have been reported by others. In a gynecology clinic at a student health center, for example, 33 percent of women with urinary tract symptoms had &ge;10",
"    <sup>",
"     5",
"    </sup>",
"    <span class=\"nowrap\">",
"     CFU/mL",
"    </span>",
"    while another 46 percent had CFU counts between 10",
"    <sup>",
"     2",
"    </sup>",
"    and",
"    <span class=\"nowrap\">",
"     10",
"     <sup>",
"      4",
"     </sup>",
"     /mL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24214/abstract/10\">",
"     10",
"    </a>",
"    ]. When asymptomatic patients were included, there was a stepwise relation between the colony count and the likelihood of symptoms.",
"   </p>",
"   <p>",
"    On the basis of these findings, it has been suggested that a CFU count",
"    <span class=\"nowrap\">",
"     &ge;10",
"     <sup>",
"      2",
"     </sup>",
"     /mL",
"    </span>",
"    be considered positive on a midstream urine specimen in women with acute symptoms and pyuria. It has been estimated that 88 percent of such women have a UTI [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24214/abstract/8\">",
"     8",
"    </a>",
"    ]. If symptoms persist and the standard bacterial culture is negative, a pelvic examination should be performed with culture of a cervical swab for Chlamydia.",
"   </p>",
"   <p>",
"    It is not well understood why some infected women have low colony counts. Two possibilities are that low counts reflect an earlier stage of infection and that low counts reflect the efficacy of bladder washout during urination to eliminate the organisms.",
"   </p>",
"   <p>",
"    There are also several other settings in which a colony count of",
"    <span class=\"nowrap\">",
"     &le;10",
"     <sup>",
"      5",
"     </sup>",
"     /mL",
"    </span>",
"    often represents true infection rather than contamination:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients already being treated with antimicrobials.",
"     </li>",
"     <li>",
"      In men in whom contamination is a much lesser problem.",
"     </li>",
"     <li>",
"      When organisms other than E. coli and Proteus are present. Included in this group are Pseudomonas, Klebsiella-Enterobacter-Serratia, and Moraxella species, particularly in symptomatic patients with an indwelling bladder catheter. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/24/44422?source=see_link\">",
"       \"Urinary tract infection associated with urethral catheters\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     DEFINITION OF PYURIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pyuria is defined as &gt;20,000",
"    <span class=\"nowrap\">",
"     leukocytes/mL",
"    </span>",
"    (by hemocytometry) in women with low count bacteriuria [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24214/abstract/10\">",
"     10",
"    </a>",
"    ]. Others have defined pyuria as the presence of at least 8000 leukocytes per mL of uncentrifuged urine, which corresponds to 2 to 5 leukocytes per high power field in a centrifuged sediment [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24214/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Given the very high association between infection and pyuria, a careful examination of the urine sediment is indicated in all patients with suspected UTI. However, assessment of pyuria is subject to some technical pitfalls [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24214/abstract/9\">",
"     9",
"    </a>",
"    ]. Two important variables are contamination with vaginal secretions in women and the volume of supernatant in which the centrifuged pellet is resuspended, which will affect the leukocyte count.",
"   </p>",
"   <p>",
"    These observations indicate that the customary determination of leukocyte counts per high-power field is not sufficiently accurate and that the use of white cell counting is preferred in the diagnosis of UTI. A significant number of leukocytes",
"    <span class=\"nowrap\">",
"     (&gt;10/microL",
"    </span>",
"    or",
"    <span class=\"nowrap\">",
"     10,000/mL)",
"    </span>",
"    should be present in truly infected patients. The presence of bacteria in the absence of pyuria, especially when various strains are found, is usually due to contamination during sampling.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Sterile pyuria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Whereas true infection without pyuria is unusual, pyuria can occur in the absence of apparent bacterial infection, particularly in patients who have already taken antimicrobials (often due to self-medication). Other causes of sterile pyuria include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Contamination of the urine sample by sterilizing solution",
"     </li>",
"     <li>",
"      Contamination of the urine sample with vaginal leukocytes",
"     </li>",
"     <li>",
"      Chronic interstitial nephritis",
"     </li>",
"     <li>",
"      Nephrolithiasis (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/50/20266?source=see_link\">",
"       \"Diagnosis and acute management of suspected nephrolithiasis in adults\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Uroepithelial tumor (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/45/1754?source=see_link\">",
"       \"Malignancies of the renal pelvis and ureter\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Painful bladder",
"      <span class=\"nowrap\">",
"       syndrome/interstitial",
"      </span>",
"      cystitis (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/8/8330?source=see_link\">",
"       \"Pathogenesis, clinical features, and diagnosis of interstitial cystitis/bladder pain syndrome\"",
"      </a>",
"      )",
"      <strong>",
"      </strong>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the case of uroepithelial tumors, both malignant cells and leukocytes are shed [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24214/abstract/11\">",
"     11",
"    </a>",
"    ]. The tumor can cause inflammation that results in the appearance or exacerbation of sterile pyuria. Malignant cells are difficult to distinguish from leukocytes on routine urinalysis.",
"   </p>",
"   <p>",
"    When the more common causes of sterile pyuria have been eliminated, patients with dysuria and frequency should be tested for atypical organisms such as Chlamydia, Ureaplasma urealyticum, or tuberculosis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24214/abstract/1,12\">",
"     1,12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/43/14005?source=see_link\">",
"     \"Renal disease in tuberculosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     DIPSTICKS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dipsticks may be used as a screening tool for diagnosis of UTI; they detect the presence of leukocyte esterase and nitrite in the urine. The dipstick nitrite test depends on the conversion of nitrate (from dietary metabolites) to nitrite by bacteria in the urine; normally no detectable nitrite is present. When bacteriuria is significant, the test is positive about 80 percent of cases in which the urine has incubated for at least four hours in the bladder [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24214/abstract/13\">",
"     13",
"    </a>",
"    ]. Leukocyte esterase corresponds to pyuria and nitrite reflects the presence of Enterobacteriaceae, which convert urinary nitrate to nitrite [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24214/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. In one study, dipstick was comparable to urinalysis for UTI screening; both had high false positive and false negative rates [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24214/abstract/16\">",
"     16",
"    </a>",
"    ]. A negative dipstick in a patient with symptoms of UTI may represent false negative results, and a urine culture should be performed [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24214/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a review of six studies including women aged 17 to 70 with suspected UTI in primary care settings, positive dipstick findings (nitrite or leukocyte esterase and blood) had sensitivity and specificity of 75 and 66 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24214/abstract/18\">",
"     18",
"    </a>",
"    ]. A meta-analysis including 70 publications noted concluded that urine dipstick test alone is useful when both nitrite and leukocyte esterase tests are negative (sensitivity 68 to 88 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24214/abstract/19\">",
"     19",
"    </a>",
"    ]. A systematic review including 30 studies noted that a positive leukocyte esterase or nitrite test had the highest sensitivity and the lowest negative likelihood ratio [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24214/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Subsequent studies reveal fewer positive results of the dipstick test. A total of 434 adult females with suspected lower UTI in a primary care setting were assessed. Presence of blood was a criterion added to the nitrite and leukocyte esterase tests. Sixty-six patients had confirmed UTI. Clinical criteria (urine cloudiness, dysuria and nocturia) were also taken into account. The negative predictive value was 67 percent for none of the features, and the positive value was 82 percent for three features. The authors concluded that dipstick results can modestly improve, but poorly rule out infection [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24214/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Among 2252 women with overactive bladder, dipstick test was not sufficient to identify patients with UTI (sensitivity and specificity 44 and 86 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24214/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thus, a positive test is a reliable index of significant bacteriuria, though a negative test does not exclude bacteriuria. Reasons for a negative nitrite test in the presence of bacteriuria include insufficient bladder incubation time for conversion of nitrate to nitrite, low urinary excretion of nitrate, inability of some organisms to convert nitrate to nitrite (such as E. faecalis) and decreased urine pH (due to cranberry juice or other dietary supplements).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?31/18/32036?source=see_link\">",
"       \"Patient information: Urinary tract infections in adolescents and adults (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H106755062\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among patients with symptoms suggestive of a UTI (dysuria and frequency), the diagnosis can be confirmed by sending a clean-catch specimen for culture and for urinalysis. One suggested exception recommended by most experts is a symptomatic young woman with pyuria (detected by urinalysis or dipstick) who has apparently uncomplicated cystitis. It has been proposed that this constellation of findings is sufficiently diagnostic that an empiric course (usually three days) of antimicrobial therapy can be initiated without performing a urine culture. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The indications for culture in young women are:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Suspicion of a complicated infection",
"     </li>",
"     <li>",
"      Atypical symptoms",
"     </li>",
"     <li>",
"      Failure to respond to initial therapy, raising the possibility of a resistant organism",
"     </li>",
"     <li>",
"      Recurrent symptoms less than one month after treatment of a previous UTI for which no culture was performed (see",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The standard definition of a positive urine culture is &ge;10",
"      <sup>",
"       5",
"      </sup>",
"      <span class=\"nowrap\">",
"       CFU/mL",
"      </span>",
"      together with pyuria (eg, leukocyte count &ge;10",
"      <sup>",
"       5",
"      </sup>",
"      <span class=\"nowrap\">",
"       WBC/mL).",
"      </span>",
"      Normal values in a noninfected midstream, clean-catch sample are &lt;10",
"      <sup>",
"       5",
"      </sup>",
"      colony-forming units (CFU, primarily due to contaminating Escherichia coli) and &lt;10,000 leukocytes per mL of urine. Contamination in the absence of UTI is typically suggested by high CFU counts without significant leukocyturia in a patient with no urinary tract symptoms, such as dysuria, frequency, or fever. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Definition of a positive culture'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      It has been suggested that a CFU count",
"      <span class=\"nowrap\">",
"       &ge;10",
"       <sup>",
"        2",
"       </sup>",
"       /mL",
"      </span>",
"      be considered positive on a midstream urine specimen in women with acute symptoms and pyuria. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Definition of a positive culture'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Whereas true infection without pyuria is unusual, pyuria can occur in the absence of apparent bacterial infection, particularly in patients who have already taken antimicrobials (often due to self-medication). Other causes of sterile pyuria include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Contamination of the urine sample by sterilizing solution",
"     </li>",
"     <li>",
"      Contamination of the urine sample with vaginal leukocytes",
"     </li>",
"     <li>",
"      Chronic interstitial nephritis",
"     </li>",
"     <li>",
"      Nephrolithiasis",
"     </li>",
"     <li>",
"      Uroepithelial tumor (see",
"      <a class=\"local\" href=\"#H5\">",
"       'Sterile pyuria'",
"      </a>",
"      above)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      When the more common causes of sterile pyuria have been eliminated, patients with dysuria and frequency should be tested for atypical organisms, such as Chlamydia, Ureaplasma urealyticum, or tuberculosis. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Sterile pyuria'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Dipsticks may be used as a screening tool for diagnosis of UTI; normally, no detectable nitrite is present. When bacteriuria is significant, the test is positive about 80 percent of cases in which the urine has incubated for at least four hours in the bladder. Leukocyte esterase corresponds to pyuria and nitrite reflects the presence of Enterobacteriaceae, which convert urinary nitrate to nitrite. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Dipsticks'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24214/abstract/1\">",
"      Stamm WE, Wagner KF, Amsel R, et al. Causes of the acute urethral syndrome in women. N Engl J Med 1980; 303:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24214/abstract/2\">",
"      Wilson ML, Gaido L. Laboratory diagnosis of urinary tract infections in adult patients. Clin Infect Dis 2004; 38:1150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24214/abstract/3\">",
"      KASS EH. Asymptomatic infections of the urinary tract. Trans Assoc Am Physicians 1956; 69:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24214/abstract/4\">",
"      Platt R. Quantitative definition of bacteriuria. Am J Med 1983; 75:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24214/abstract/5\">",
"      Pollock HM. Laboratory techniques for detection of urinary tract infection and assessment of value. Am J Med 1983; 75:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24214/abstract/6\">",
"      SANFORD JP, FAVOUR CB, MAO FH, HARRISON JH. Evaluation of the positive urine culture; an approach to the differentiation of significant bacteria from contaminants. Am J Med 1956; 20:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24214/abstract/7\">",
"      Tapsall JW, Taylor PC, Bell SM, Smith DD. Relevance of \"significant bacteriuria\" to aetiology and diagnosis of urinary-tract infection. Lancet 1975; 2:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24214/abstract/8\">",
"      Stamm WE, Counts GW, Running KR, et al. Diagnosis of coliform infection in acutely dysuric women. N Engl J Med 1982; 307:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24214/abstract/9\">",
"      Komaroff AL. Acute dysuria in women. N Engl J Med 1984; 310:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24214/abstract/10\">",
"      Kunin CM, White LV, Hua TH. A reassessment of the importance of \"low-count\" bacteriuria in young women with acute urinary symptoms. Ann Intern Med 1993; 119:454.",
"     </a>",
"    </li>",
"    <li>",
"     Eagan JW. Urinary tract cytology. In: Uropathology, Hill GS (Ed), Churchill Livingstone, Philadelphia 1989. Vol 2, p.873.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24214/abstract/12\">",
"      McDonald MI, Lam MH, Birch DF, et al. Ureaplasma urealyticum in patients with acute symptoms of urinary tract infection. J Urol 1982; 128:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24214/abstract/13\">",
"      Williams GJ, Macaskill P, Chan SF, et al. Absolute and relative accuracy of rapid urine tests for urinary tract infection in children: a meta-analysis. Lancet Infect Dis 2010; 10:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24214/abstract/14\">",
"      McNeeley SG, Baselski VS, Ryan GM. An evaluation of two rapid bacteriuria screening procedures. Obstet Gynecol 1987; 69:550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24214/abstract/15\">",
"      Pfaller MA, Koontz FP. Laboratory evaluation of leukocyte esterase and nitrite tests for the detection of bacteriuria. J Clin Microbiol 1985; 21:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24214/abstract/16\">",
"      Lammers RL, Gibson S, Kovacs D, et al. Comparison of test characteristics of urine dipstick and urinalysis at various test cutoff points. Ann Emerg Med 2001; 38:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24214/abstract/17\">",
"      Koeijers JJ, Kessels AG, Nys S, et al. Evaluation of the nitrite and leukocyte esterase activity tests for the diagnosis of acute symptomatic urinary tract infection in men. Clin Infect Dis 2007; 45:894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24214/abstract/18\">",
"      Little P, Turner S, Rumsby K, et al. Dipsticks and diagnostic algorithms in urinary tract infection: development and validation, randomised trial, economic analysis, observational cohort and qualitative study. Health Technol Assess 2009; 13:iii.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24214/abstract/19\">",
"      Devill&eacute; WL, Yzermans JC, van Duijn NP, et al. The urine dipstick test useful to rule out infections. A meta-analysis of the accuracy. BMC Urol 2004; 4:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24214/abstract/20\">",
"      St John A, Boyd JC, Lowes AJ, Price CP. The use of urinary dipstick tests to exclude urinary tract infection: a systematic review of the literature. Am J Clin Pathol 2006; 126:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24214/abstract/21\">",
"      Little P, Turner S, Rumsby K, et al. Validating the prediction of lower urinary tract infection in primary care: sensitivity and specificity of urinary dipsticks and clinical scores in women. Br J Gen Pract 2010; 60:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24214/abstract/22\">",
"      Hessdoerfer E, Jundt K, Peschers U. Is a dipstick test sufficient to exclude urinary tract infection in women with overactive bladder? Int Urogynecol J 2011; 22:229.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8056 Version 16.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-425BDFC11D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_41_24214=[""].join("\n");
var outline_f23_41_24214=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H106755062\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      URINE SAMPLING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DEFINITION OF A POSITIVE CULTURE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      DEFINITION OF PYURIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Sterile pyuria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      DIPSTICKS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H106755062\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/47/10999?source=related_link\">",
"      Acute complicated cystitis and pyelonephritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/15/13561?source=related_link\">",
"      Acute uncomplicated cystitis and pyelonephritis in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/60/23496?source=related_link\">",
"      Chronic bacterial prostatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/50/20266?source=related_link\">",
"      Diagnosis and acute management of suspected nephrolithiasis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/45/1754?source=related_link\">",
"      Malignancies of the renal pelvis and ureter",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/15/35059?source=related_link\">",
"      Microbiology specimen collection and transport",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/8/8330?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of interstitial cystitis/bladder pain syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?31/18/32036?source=related_link\">",
"      Patient information: Urinary tract infections in adolescents and adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/43/14005?source=related_link\">",
"      Renal disease in tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/24/44422?source=related_link\">",
"      Urinary tract infection associated with urethral catheters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/56/42886?source=related_link\">",
"      Urine collection techniques in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_41_24215="Pathobiology of follicular lymphoma";
var content_f23_41_24215=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathobiology of follicular lymphoma",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/41/24215/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/41/24215/contributors\">",
"     Jennifer R Brown, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/41/24215/contributors\">",
"     Arnold S Freedman, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/41/24215/contributors\">",
"     Jon C Aster, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/41/24215/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/41/24215/contributors\">",
"     Andrew Lister, MD, FRCP, FRCPath, FRCR",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/41/24215/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/41/24215/contributors\">",
"     Rebecca F Connor, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/41/24215/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 26, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H26243868\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Follicular lymphoma (FL) is the second most common subtype of non-Hodgkin lymphomas. It is defined as a lymphoma of follicle center B cells, and virtually always demonstrates a growth pattern that is partially follicular. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/53/21337?source=see_link\">",
"     \"Classification of the hematopoietic neoplasms\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The molecular pathogenesis of FL is a complex, multistep process leading to the replication of a malignant clone of germinal center B cells, both centrocytes (small cleaved follicular center cells) and centroblasts (large noncleaved follicular center cells). While some steps in this pathway have been elucidated, many remain unknown. There are genetic lesions that affect large chromosomal regions (eg, rearrangements of BCL-2) and somatic mutations, some of which are also seen in other non-Hodgkin lymphoma variants. In the case of some of these abnormalities, these shared genetic lesions may reflect in part the not uncommon evolution of FL into a more aggressive lymphoma, such as diffuse large B cell lymphoma, referred to as histologic transformation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/19/5433?source=see_link\">",
"     \"Pathobiology and treatment of histologic transformation in the indolent non-Hodgkin lymphomas\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This review will discuss the pathobiology of FL in adults. In contrast, FL that develops in children appears to have distinctive clinical and pathologic features. The epidemiology, clinical presentation, pathologic features, diagnosis, treatment, and prognosis of FL are discussed separately. General aspects of the pathobiology of non-Hodgkin lymphoma are also discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/46/25322?source=see_link\">",
"     \"Clinical manifestations, pathologic features, diagnosis, and prognosis of follicular lymphoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/40/9865?source=see_link\">",
"     \"Initial treatment of limited stage (I/II) follicular lymphoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/10/7338?source=see_link\">",
"     \"Treatment of relapsed or refractory follicular lymphoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/53/29529?source=see_link\">",
"     \"Overview of the pathobiology of the non-Hodgkin lymphomas\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26244312\">",
"    <span class=\"h1\">",
"     CELL OF ORIGIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;FL is a heterogeneous clinicopathologic entity that includes tumors derived from germinal center B cells, both centrocytes (small cleaved follicular center cells) and centroblasts (large noncleaved follicular center cells) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/1\">",
"     1",
"    </a>",
"    ]. The germinal center ancestry of these cells is principally supported by the identification of somatic mutations in the variable region of the immunoglobulin genes (IgVH), which serves as a marker of germinal center transit [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/53/29529?source=see_link&amp;anchor=H38692429#H38692429\">",
"     \"Overview of the pathobiology of the non-Hodgkin lymphomas\", section on 'B cell lymphoma'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H91137362\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H91137370\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;The development of the majority of FL tumors in adults is dependent upon the overexpression of B cell",
"    <span class=\"nowrap\">",
"     leukemia/lymphoma",
"    </span>",
"    2 (BCL-2) located on chromosome band 18q21. BCL-2 is an oncogene that blocks programmed cell death (apoptosis). As such, overexpression results in prolonged cell survival. BCL-2 overexpression in itself is not sufficient for FL development and other genetic lesions or host factors are required (",
"    <a class=\"graphic graphic_figure graphicRef56311 \" href=\"UTD.htm?41/12/42182\">",
"     figure 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H26243882\">",
"     'Other genetic lesions'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    BCL-2 overexpression is virtually always the result of a translocation that places the BCL-2 gene under the control of an immunoglobulin promoter. Of these, the t(14;18)(q32;q21) is most common and places BCL-2 under the control of the IgH locus, but variant translocations occur that place BCL-2 under the control of the kappa or lambda immunoglobulin loci. (See",
"    <a class=\"local\" href=\"#H26243875\">",
"     'Translocations involving BCL-2'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    These aberrations likely represent mistakes that occur during attempted antigen receptor gene rearrangements in normal B cells. In the bone marrow, pre-B cells rearrange the V(D)J segments of their immunoglobulin (Ig) loci to allow expression of IgM. This process, termed V(D)J recombination, requires the recombination activating genes RAG1 and RAG2. Subsequently, in the germinal center, antigen stimulated B cells undergo class-switch recombination (from IgM to IgG or IgA) and somatic hypermutation. Somatic hypermutation, a key component of the humoral immune response, is the process by which point mutations and small deletions or insertions are introduced at high frequency into the variable regions of immunoglobulin heavy chain genes. Both class switch recombination and somatic hypermutation require the enzyme activation-induced cytidine deaminase (AID).",
"   </p>",
"   <p>",
"    The sequences found immediately adjacent to the points of DNA breakage and rejoining in",
"    <span class=\"nowrap\">",
"     BCL-2/Ig",
"    </span>",
"    translocations implicate",
"    <span class=\"nowrap\">",
"     RAG1/RAG2",
"    </span>",
"    in the process [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/3\">",
"     3",
"    </a>",
"    ]. It remains uncertain whether these RAG mediated breaks occur in pre-B cells or during antigen receptor gene &ldquo;editing&rdquo; in germinal center B cells. Cells bearing such rearrangements gain a selective advantage when the consequence is overexpression of an oncogene such as BCL-2. AID-mediated class-switching and somatic hypermutation is also error-prone, and it is strongly suspected that additional AID-dependent mutations introduced by these processes in germinal center B cells contribute to the development of FL. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/53/29529?source=see_link&amp;anchor=H3#H3\">",
"     \"Overview of the pathobiology of the non-Hodgkin lymphomas\", section on 'Chromosomal translocations'",
"    </a>",
"    .) Since FL often shows evidence of ongoing somatic hypermutation, it is possible that AID contributes to acquisition of additional mutations that are involved in FL development and progression.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26244320\">",
"    <span class=\"h2\">",
"     Aberrant BCL-2 expression",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H91137600\">",
"    <span class=\"h3\">",
"     BCL-2 action",
"    </span>",
"    &nbsp;&mdash;&nbsp;The B cell",
"    <span class=\"nowrap\">",
"     leukemia/lymphoma",
"    </span>",
"    2 (BCL-2) gene encodes a 26-kDa integral membrane protein localized to the outer mitochondrial membrane and endoplasmic reticulum [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/4\">",
"     4",
"    </a>",
"    ]. In contrast to most proto-oncogenes, BCL-2 has little or no ability to promote cell cycle progression or cell proliferation, but rather lowers the cellular apoptotic threshold by inhibiting programmed cell death. Normally in germinal center B cells, BCL-2 expression is restricted to cells that, through the process of somatic hypermutation, by chance acquire Ig with high affinity for antigen; these cells are thought to then emerge from germinal centers as long-surviving memory B cells [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/4\">",
"     4",
"    </a>",
"    ] or to differentiate into plasma cells. This hypothesis is supported by data from BCL-2 transgenic animals that show markedly protracted secondary immune responses and an extended lifetime for memory B cells in the absence of antigen [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Apoptosis (programmed cell death) is an essential part of embryo development, maintaining tissue homeostasis, and developing the immune system. In contrast, processes that interfere with normal apoptosis promote cell survival and, potentially, oncogenesis. Apoptosis is regulated by a balance of pro-apoptotic factors and anti-apoptotic factors [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/7\">",
"     7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pro-apoptotic factors &mdash; Two categories of pro-apoptotic factors exist, one consisting of multi-domain proteins (eg, BAX and BAK), and the second consisting of single BH3-domain only proteins (eg, BAD and BID). Both types of pro-apoptotic proteins are needed to initiate intrinsic apoptosis. The single BH3 domain proteins send the signal to trigger death; once activated, they in turn activate BAX, which aggregates in the mitochondrial membrane. This aggregation promotes apoptosis by releasing cytochrome c from the mitochondria, which leads to the activation of caspase-9 followed by caspase-3, resulting in protein and DNA cleavage [",
"      <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/8-10\">",
"       8-10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Anti-apoptotic factors &mdash; BCL-2, BCL-XL and MCL-1 are examples of anti-apoptotic factors. Although the mechanism is not completely understood, these anti-apoptotic factors prevent the release of mitochondrial proteins, such as cytochrome c, thereby preventing the activation of caspase-9.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    FL demonstrates increased expression of the anti-apoptotic factors (BCL-2, BCL-XL, and MCL1) and very low or undetectable amounts of pro-apoptotic factors (BAX and BAD) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. This imbalance promotes cell survival.",
"   </p>",
"   <p>",
"    How BCL-2 translocations contribute to the development of FL is complex and incompletely understood. It has long been known that",
"    <span class=\"nowrap\">",
"     BCL-2/IgH",
"    </span>",
"    translocations can be detected at low frequency (ie, one cell in 1000 to one cell in 10,000) in the germinal centers of a high fraction of normal individuals, almost none of whom will go on to develop FL [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. Similarly, highly sensitive methods can detect t(14;18) at low levels in the peripheral blood of some healthy individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. One study found that these individuals carry this translocation within a population of atypical germinal center-type B cells that have phenotypic features of FL [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/17\">",
"     17",
"    </a>",
"    ]. The natural history of persons with low levels of circulating clones resembling FL is not known. These observations clearly indicate that",
"    <span class=\"nowrap\">",
"     BCL-2/IgH",
"    </span>",
"    translocations are not sufficient to cause FL, and that other genetic or epigenetic events are rate limiting for its development.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26243875\">",
"    <span class=\"h3\">",
"     Translocations involving BCL-2",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the vast majority of cases, FL is associated with a translocation between the long arm of chromosome 18, the site of the BCL-2 oncogene (18q21), and one of three locations on immunoglobulin (Ig) genes [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Ig heavy chain gene on chromosome 14 &mdash; resulting in the t(14;18)(q32;q21) found in approximately 85 percent of FL.",
"     </li>",
"     <li>",
"      The kappa light chain gene on chromosome 2 &mdash; resulting in the t(2;18)(p11;q21), which is uncommon but considered a biologic equivalent.",
"     </li>",
"     <li>",
"      The lambda light chain gene on chromosome 22 &mdash; resulting in the t(18;22)(q21;q21), which is uncommon but considered a biologic equivalent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The consequence of these translocations is the presence within the cells of constitutively high levels of BCL-2 protein, resulting from both enhanced transcription and, possibly, more efficient RNA processing (",
"    <a class=\"graphic graphic_picture graphicRef64808 \" href=\"UTD.htm?37/54/38761\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/20,21\">",
"     20,21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H174935843\">",
"    <span class=\"h2\">",
"     BCL-2 negative cases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Less than 10 percent of FL tumors do not harbor BCL-2 translocations and do not express BCL-2 protein [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/22\">",
"     22",
"    </a>",
"    ]. These tumors have gene expression profiles that are distinct from BCL-2 expressing tumors and may be a different clinicopathologic entity [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/23\">",
"     23",
"    </a>",
"    ]. BCL-2 negativity is most commonly seen in grade IIIB FL, in which the tumor is comprised of solid sheets of centroblasts that grow in a follicular pattern [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/46/25322?source=see_link&amp;anchor=H11#H11\">",
"     \"Clinical manifestations, pathologic features, diagnosis, and prognosis of follicular lymphoma\", section on 'Grade'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical course of grade IIIB FL is generally more similar to that of diffuse large B cell lymphoma (DLBCL) than that of FL grades I and II. One study using cytogenetics demonstrated that this morphologic subgroup includes [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/25\">",
"     25",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Tumors with the t(14;18) affecting BCL-2",
"     </li>",
"     <li>",
"      Tumors with 3q27 rearrangements affecting BCL-6",
"     </li>",
"     <li>",
"      Tumors that lack either of these characteristic cytogenetic abnormalities",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The same molecular subdivisions exist in DLBCL, leading to the suggestion that the lymphomas with t(14;18) may be more similar to FL grades I and II, while the other two subtypes are more related to de novo DLBCL [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/25\">",
"     25",
"    </a>",
"    ]. Although this series suggested that BCL-6 rearrangements and BCL-2 rearrangements are mutually exclusive in FL, subsequent studies have identified rare tumors with both rearrangements [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/26\">",
"     26",
"    </a>",
"    ]. In either case, BCL-6 expression may play a role in the pathogenesis of a subset of grade IIIB FL. BCL-6 encodes a transcription factor that is essential for normal germinal center B cell development. Expression of BCL-6 in normal germinal center B cells down-regulates genes that sense DNA damage, such as the p53 tumor suppressor gene, which would otherwise trigger apoptosis in response to the physiologic DNA rearrangements of the germinal center. This is described in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/27/38329?source=see_link&amp;anchor=H3#H3\">",
"     \"Pathobiology of diffuse large B cell lymphoma and primary mediastinal large B cell lymphoma\", section on 'Aberrant BCL-6 expression'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26244328\">",
"    <span class=\"h2\">",
"     Other mechanisms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because BCL-2 overexpression is not sufficient for FL development, other genetic lesions or host factors must be required. The need for additional factors is supported by the observation that BCL-2 transgenic mice develop a pattern of polyclonal hyperplasia of mature, long lived B cells resting in G(0) rather than clonal FL [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. With time, and analogous to the human disease, a fraction of BCL-2 transgenic mice develops aggressive, clonal large cell lymphomas, which have acquired additional genetic lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/27\">",
"     27",
"    </a>",
"    ]. Additional mechanisms for the development of FL are largely unknown, but initial studies suggest a role for additional genetic lesions",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the tumor microenvironment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26243882\">",
"    <span class=\"h2\">",
"     Other genetic lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 90 percent of FL will demonstrate genetic alterations in addition to the t(14;18) translocation [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/1\">",
"     1",
"    </a>",
"    ]. The most common of these are loss of 1p, 6q, 10q, and 17p and gains of chromosomes 1, 6p, 7, 8, 12q, X, and",
"    <span class=\"nowrap\">",
"     18q/dup.",
"    </span>",
"    As an example, deletions of chromosome 6 involving the long arm occur in approximately 20 percent of cases and have been associated with poor prognosis and survival in multiple studies [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/28-30\">",
"     28-30",
"    </a>",
"    ]. Another region affected by both deletions and uniparental disomy and previously associated with poor prognosis is 1p36, shown to affect the TNFRSF14 gene [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/31\">",
"     31",
"    </a>",
"    ]. In contrast, other proto-oncogenes involved in lymphomagenesis (eg, c-MYC, BCL-1) are not involved in FL. However, about 5 to 15 percent of FLs have 3q27 abnormalities, involving the BCL-6 gene that is commonly involved in the pathogenesis of diffuse large B cell lymphoma [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H174935843\">",
"     'BCL-2 negative cases'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Efforts focused on genome sequencing have identified an unexpected role for mutation of histone-modifying genes in FL. One study reported that 41 percent of FLs were reported to harbor genomic deletions or somatic mutations affecting primarily the CREBBP gene and, less commonly, the EP300 gene, which function as acetyltransferases and act as transcriptional coactivators [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/32\">",
"     32",
"    </a>",
"    ]. A subsequent study found that 89 percent of FLs harbor mutations in MLL2, which is a histone methyltransferase, and 13 percent of cases had mutations in MEF2B, a gene that cooperates with CREBBP and EP300 in acetylating histones [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/33\">",
"     33",
"    </a>",
"    ]. The mechanism by which these genes promote FL remains to be elucidated. It is of interest that all of these genes were also found to be frequently mutated in diffuse large B cell lymphoma.",
"   </p>",
"   <p>",
"    The number of additional genetic lesions increases with histologic grade, being most common with grade IIIb histology. Over time, a significant fraction of FL evolves into an aggressive lymphoma with a diffuse large cell architecture [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/34\">",
"     34",
"    </a>",
"    ]. This histologic shift is associated with p53 loss-of-function mutations [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/35-37\">",
"     35-37",
"    </a>",
"    ]. Rearrangements of 1q21-23 have been identified in a subset of FL during disease progression. In cases where t(1;22)(q22;q11) was identified, the target gene is FCGR2B, which encodes the IgG Fc receptor, FcgammaRIIB. Since FcgammaRIIB is involved in regulating B cell proliferation, deregulation is likely to be important in the progression of FL [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/38\">",
"     38",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/19/5433?source=see_link&amp;anchor=H8#H8\">",
"     \"Pathobiology and treatment of histologic transformation in the indolent non-Hodgkin lymphomas\", section on 'Cytogenetics'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H91138016\">",
"    <span class=\"h2\">",
"     Tumor microenvironment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The tumor microenvironment, specifically the immunologic microenvironment comprised of T cells and dendritic cells, may influence the development and progression of FL [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/39-43\">",
"     39-43",
"    </a>",
"    ]. It has been suggested that FL is an immunologically functional disease in which an interaction between the tumor cells and the microenvironment determines overall clinical behavior.",
"   </p>",
"   <p>",
"    The role of the microenvironment is supported by gene expression profiling and immunophenotypic studies that have correlated patient survival with the expression pattern of the immune cells accompanying the lymphoma, rather than with the expression pattern of the lymphoma itself [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/44-47\">",
"     44-47",
"    </a>",
"    ]. Communication between the tumor cells and the microenvironment likely involves chemokines, chemokine receptors and adhesion molecules, the balance of which determines whether there is tumor cell growth promotion or inhibition [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. Comparison of gene expression between purified FL cells and normal germinal center B cells has found upregulation of cell cycle mediators, B cell transcription factors, certain cytokines, and genes involved in cell-cell interactions [",
"    <a class=\"abstract\" href=\"UTD.htm?23/41/24215/abstract/50\">",
"     50",
"    </a>",
"    ]. These differences are consistent with a role for the microenvironment in tumor pathogenesis that requires further clarification. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/46/25322?source=see_link&amp;anchor=H75815126#H75815126\">",
"     \"Clinical manifestations, pathologic features, diagnosis, and prognosis of follicular lymphoma\", section on 'Microenvironment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H91138008\">",
"    <span class=\"h1\">",
"     HETEROGENEITY OF FL",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnostic category of FL is heterogeneous in terms of morphology, genetics, and biologic behavior. However, it is difficult to reliably subclassify FL into morphologic variants. It is likely that the heterogeneity of FL depends upon a variety of factors including differences in the tumor microenvironment and gene expression. As an example, BCL-2 negative tumors demonstrate a gene expression profile that is distinct from BCL-2 expressing tumors and may represent a different clinicopathologic entity. (See",
"    <a class=\"local\" href=\"#H174935843\">",
"     'BCL-2 negative cases'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26244291\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Follicular lymphoma (FL) is the second most common histologic subtype of non-Hodgkin lymphoma. The molecular pathogenesis of FL is a complex, multistep process leading to the replication of a malignant clone of germinal B cell origin (",
"      <a class=\"graphic graphic_figure graphicRef56311 \" href=\"UTD.htm?41/12/42182\">",
"       figure 1",
"      </a>",
"      ). While some steps in this pathway have been elucidated, many remain unknown. (See",
"      <a class=\"local\" href=\"#H26244312\">",
"       'Cell of origin'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The development of the majority of FL tumors in adults is associated with the overexpression of B cell",
"      <span class=\"nowrap\">",
"       leukemia/lymphoma",
"      </span>",
"      2 (BCL-2) located on chromosome band 18q21. BCL-2 is an oncogene that blocks programmed cell death (apoptosis). As such, overexpression results in prolonged cell survival. (See",
"      <a class=\"local\" href=\"#H26244320\">",
"       'Aberrant BCL-2 expression'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In the vast majority of cases, FL is associated with a translocation between the long arm of chromosome 18, the site of the BCL-2 oncogene, and one of the three immunoglobulin (Ig) genes. The most common translocation involves the Ig heavy chain gene resulting in the t(14;18)(q32;q21) found in approximately 85 percent of FL. (See",
"      <a class=\"local\" href=\"#H26243875\">",
"       'Translocations involving BCL-2'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Less than 10 percent of FL tumors lack BCL-2 translocations and fail to express BCL-2 proteins. BCL-2 negativity is most commonly seen in grade IIIB FL, in which the tumor is comprised of solid sheets of centroblasts that nonetheless form a follicular pattern. (See",
"      <a class=\"local\" href=\"#H174935843\">",
"       'BCL-2 negative cases'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      BCL-2 overexpression in itself is not sufficient for FL development and other genetic lesions or host factors are required. Additional mechanisms for the development of FL are largely unknown, but initial studies suggest roles for genetic lesions involving genes that regulate histone modification, chromatin structure, and gene expression, as well as the local host response that generates the tumor microenvironment. (See",
"      <a class=\"local\" href=\"#H26244328\">",
"       'Other mechanisms'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Swerdlow SH, Campo E, Harris NL, et al. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, IARC Press, Lyon 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/2\">",
"      Ottensmeier CH, Thompsett AR, Zhu D, et al. Analysis of VH genes in follicular and diffuse lymphoma shows ongoing somatic mutation and multiple isotype transcripts in early disease with changes during disease progression. Blood 1998; 91:4292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/3\">",
"      Raghavan SC, Swanson PC, Wu X, et al. A non-B-DNA structure at the Bcl-2 major breakpoint region is cleaved by the RAG complex. Nature 2004; 428:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/4\">",
"      Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992; 80:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/5\">",
"      Nu&ntilde;ez G, Hockenbery D, McDonnell TJ, et al. Bcl-2 maintains B cell memory. Nature 1991; 353:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/6\">",
"      McDonnell TJ, Deane N, Platt FM, et al. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 1989; 57:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/7\">",
"      Cory S, Adams JM. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2002; 2:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/8\">",
"      Cory S, Adams JM. Killing cancer cells by flipping the Bcl-2/Bax switch. Cancer Cell 2005; 8:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/9\">",
"      Boise LH, Gonz&aacute;lez-Garc&iacute;a M, Postema CE, et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993; 74:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/10\">",
"      Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/11\">",
"      Yang E, Korsmeyer SJ. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 1996; 88:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/12\">",
"      Ghia P, Boussiotis VA, Schultze JL, et al. Unbalanced expression of bcl-2 family proteins in follicular lymphoma: contribution of CD40 signaling in promoting survival. Blood 1998; 91:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/13\">",
"      Limpens J, de Jong D, van Krieken JH, et al. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 1991; 6:2271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/14\">",
"      Aster JC, Kobayashi Y, Shiota M, et al. Detection of the t(14;18) at similar frequencies in hyperplastic lymphoid tissues from American and Japanese patients. Am J Pathol 1992; 141:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/15\">",
"      Limpens J, Stad R, Vos C, et al. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood 1995; 85:2528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/16\">",
"      D&ouml;lken G, Illerhaus G, Hirt C, Mertelsmann R. BCL-2/JH rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases. J Clin Oncol 1996; 14:1333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/17\">",
"      Roulland S, Navarro JM, Grenot P, et al. Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis. J Exp Med 2006; 203:2425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/18\">",
"      Bloomfield CD, Arthur DC, Frizzera G, et al. Nonrandom chromosome abnormalities in lymphoma. Cancer Res 1983; 43:2975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/19\">",
"      Rowley JD. Chromosome studies in the non-Hodgkin's lymphomas: the role of the 14;18 translocation. J Clin Oncol 1988; 6:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/20\">",
"      Graninger WB, Seto M, Boutain B, et al. Expression of Bcl-2 and Bcl-2-Ig fusion transcripts in normal and neoplastic cells. J Clin Invest 1987; 80:1512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/21\">",
"      Ngan BY, Chen-Levy Z, Weiss LM, et al. Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation. N Engl J Med 1988; 318:1638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/22\">",
"      Schraders M, de Jong D, Kluin P, et al. Lack of Bcl-2 expression in follicular lymphoma may be caused by mutations in the BCL2 gene or by absence of the t(14;18) translocation. J Pathol 2005; 205:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/23\">",
"      Leich E, Salaverria I, Bea S, et al. Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations. Blood 2009; 114:826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/24\">",
"      Ott G, Katzenberger T, Lohr A, et al. Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood 2002; 99:3806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/25\">",
"      Bosga-Bouwer AG, van Imhoff GW, Boonstra R, et al. Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive. Blood 2003; 101:1149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/26\">",
"      D&iacute;az-Alderete A, Doval A, Camacho F, et al. Frequency of BCL2 and BCL6 translocations in follicular lymphoma: relation with histological and clinical features. Leuk Lymphoma 2008; 49:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/27\">",
"      Ye BH, Lista F, Lo Coco F, et al. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 1993; 262:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/28\">",
"      Gaidano G, Ballerini P, Gong JZ, et al. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 1991; 88:5413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/29\">",
"      Schwaenen C, Viardot A, Berger H, et al. Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status. Genes Chromosomes Cancer 2009; 48:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/30\">",
"      Cheung KJ, Shah SP, Steidl C, et al. Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances. Blood 2009; 113:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/31\">",
"      Launay E, Pangault C, Bertrand P, et al. High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis. Leukemia 2012; 26:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/32\">",
"      Pasqualucci L, Dominguez-Sola D, Chiarenza A, et al. Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 2011; 471:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/33\">",
"      Morin RD, Mendez-Lago M, Mungall AJ, et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 2011; 476:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/34\">",
"      Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84:1361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/35\">",
"      Lo Coco F, Gaidano G, Louie DC, et al. p53 mutations are associated with histologic transformation of follicular lymphoma. Blood 1993; 82:2289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/36\">",
"      Sander CA, Yano T, Clark HM, et al. p53 mutation is associated with progression in follicular lymphomas. Blood 1993; 82:1994.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/37\">",
"      O'Shea D, O'Riain C, Taylor C, et al. The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival. Blood 2008; 112:3126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/38\">",
"      Callanan MB, Le Baccon P, Mossuz P, et al. The IgG Fc receptor, FcgammaRIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma. Proc Natl Acad Sci U S A 2000; 97:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/39\">",
"      Bende RJ, Smit LA, van Noesel CJ. Molecular pathways in follicular lymphoma. Leukemia 2007; 21:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/40\">",
"      de Jong D. Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors. J Clin Oncol 2005; 23:6358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/41\">",
"      Carbone A, Gloghini A, Gruss HJ, Pinto A. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease. Am J Pathol 1995; 147:912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/42\">",
"      Petrasch S, Kosco M, Schmitz J, et al. Follicular dendritic cells in non-Hodgkin-lymphoma express adhesion molecules complementary to ligands on neoplastic B-cells. Br J Haematol 1992; 82:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/43\">",
"      Lindhout E, Mevissen ML, Kwekkeboom J, et al. Direct evidence that human follicular dendritic cells (FDC) rescue germinal centre B cells from death by apoptosis. Clin Exp Immunol 1993; 91:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/44\">",
"      Dave SS, Wright G, Tan B, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 2004; 351:2159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/45\">",
"      Alvaro T, Lejeune M, Salvad&oacute; MT, et al. Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients. J Clin Oncol 2006; 24:5350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/46\">",
"      Farinha P, Masoudi H, Skinnider BF, et al. Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). Blood 2005; 106:2169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/47\">",
"      Glas AM, Knoops L, Delahaye L, et al. Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma. J Clin Oncol 2007; 25:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/48\">",
"      Coupland SE. The challenge of the microenvironment in B-cell lymphomas. Histopathology 2011; 58:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/49\">",
"      Laurent C, M&uuml;ller S, Do C, et al. Distribution, function, and prognostic value of cytotoxic T lymphocytes in follicular lymphoma: a 3-D tissue-imaging study. Blood 2011; 118:5371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/41/24215/abstract/50\">",
"      Husson H, Carideo EG, Neuberg D, et al. Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays. Blood 2002; 99:282.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16646 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-218.7.204.208-7855FF150B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_41_24215=[""].join("\n");
var outline_f23_41_24215=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26244291\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26243868\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26244312\">",
"      CELL OF ORIGIN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H91137362\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H91137370\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26244320\">",
"      Aberrant BCL-2 expression",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H91137600\">",
"      - BCL-2 action",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26243875\">",
"      - Translocations involving BCL-2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H174935843\">",
"      BCL-2 negative cases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26244328\">",
"      Other mechanisms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26243882\">",
"      Other genetic lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H91138016\">",
"      Tumor microenvironment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H91138008\">",
"      HETEROGENEITY OF FL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26244291\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/16646\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/16646|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?41/12/42182\" title=\"figure 1\">",
"      FL pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/16646|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?37/54/38761\" title=\"picture 1\">",
"      Bcl 2 staining in FL",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/53/21337?source=related_link\">",
"      Classification of the hematopoietic neoplasms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/46/25322?source=related_link\">",
"      Clinical manifestations, pathologic features, diagnosis, and prognosis of follicular lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/40/9865?source=related_link\">",
"      Initial treatment of limited stage (I/II) follicular lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/53/29529?source=related_link\">",
"      Overview of the pathobiology of the non-Hodgkin lymphomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/19/5433?source=related_link\">",
"      Pathobiology and treatment of histologic transformation in the indolent non-Hodgkin lymphomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/27/38329?source=related_link\">",
"      Pathobiology of diffuse large B cell lymphoma and primary mediastinal large B cell lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/10/7338?source=related_link\">",
"      Treatment of relapsed or refractory follicular lymphoma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_41_24216="Piperacillin and tazobactam sodium: Drug information";
var content_f23_41_24216=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Piperacillin and tazobactam sodium: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?39/20/40259?source=see_link\">",
"    see \"Piperacillin and tazobactam sodium: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?27/27/28086?source=see_link\">",
"    see \"Piperacillin and tazobactam sodium: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F210401\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Zosyn&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F210402\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      AJ-PIP/TAZ;",
"     </li>",
"     <li>",
"      Piperacillin and Tazobactam for Injection;",
"     </li>",
"     <li>",
"      Tazocin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F210424\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antibiotic, Penicillin",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F210405\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Dosing presented is based on traditional infusion method (I.V. infusion over 30 minutes) unless otherwise specified as the extended infusion method (I.V. infusion over 4 hours [unlabeled method]).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Usual dosage range:",
"     </b>",
"     I.V.: 3.375 g every 6 hours",
"     <b>",
"      or",
"     </b>",
"     4.5 g every 6-8 hours; maximum: 18 g/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Extended infusion method (unlabeled dosing): 3.375-4.5 g I.V. over 4 hours every 8 hours (Kim, 2007; Shea, 2009); an alternative regimen of 4.5 g I.V. over 3 hours every 6 hours has also been described (Kim, 2007)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     <b>",
"      Indication-specific dosing:",
"     </b>",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Diverticulitis, intra-abdominal abscess, peritonitis:",
"     </b>",
"     I.V.: 3.375 g every 6 hours;",
"     <b>",
"      Note:",
"     </b>",
"     Some clinicians use 4.5 g every 8 hours for empiric coverage since the %time&gt;MIC is similar between the regimens for most pathogens; however, this regimen is NOT recommended for nosocomial pneumonia or",
"     <i>",
"      Pseudomonas",
"     </i>",
"     coverage.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Intra-abdominal infection, complicated:",
"     </b>",
"     I.V.: 3.375 g every 6 hours for 4-7 days (provided source controlled).",
"     <b>",
"      Note:",
"     </b>",
"     Increase to 3.375 g every 4 hours or 4.5 g every 6 hours if",
"     <i>",
"      P. aeruginosa",
"     </i>",
"     is suspected. Not recommended for mild-to-moderate, community-acquired intra-abdominal infections due to risk of toxicity and the development of resistant organisms (Solomkin, 2010).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Pneumonia (nosocomial):",
"     </b>",
"     I.V.: 4.5 g every 6 hours for 7-14 days (when used empirically, combination with an aminoglycoside or antipseudomonal fluoroquinolone is recommended; consider discontinuation of additional agent if",
"     <i>",
"      P. aeruginosa",
"     </i>",
"     is not isolated)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Severe infections:",
"     </b>",
"     I.V.: 3.375 g every 6 hours for 7-10 days;",
"     <b>",
"      Note:",
"     </b>",
"     Some clinicians use 4.5 g every 8 hours for empiric coverage since the %time&gt;MIC is similar between the regimens for most pathogens; however, this regimen is NOT recommended for nosocomial pneumonia or",
"     <i>",
"      Pseudomonas",
"     </i>",
"     coverage.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Skin and soft tissue infection:",
"     </b>",
"     I.V.: 3.375 g every 6-8 hours for 7-14 days.",
"     <b>",
"      Notes:",
"     </b>",
"     When used for necrotizing infection of skin, fascia, or muscle, combination with clindamycin and ciprofloxacin is recommended (Stevens, 2005); for severe diabetic foot infections, recommended treatment duration is up to 4 weeks depending on severity of infection and response to therapy (Lipsky, 2012).",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F210418\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?27/27/28086?source=see_link\">",
"      see \"Piperacillin and tazobactam sodium: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Dosing presented is based on traditional infusion method (I.V. infusion over 30 minutes) unless otherwise specified as the extended infusion method (I.V. infusion over 4 hours [unlabeled method]).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Usual dosage range:",
"     </b>",
"     Children: I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     2-8 months: 80 mg of piperacillin component/kg every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &ge;9 months and &le;40 kg: 100 mg of piperacillin component/kg every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     <b>",
"      Indication-specific dosing:",
"     </b>",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Appendicitis, peritonitis:",
"     </b>",
"     Children:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     2-8 months: 80 mg/kg every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     &ge;9 months and &le;40 kg: 100 mg/kg every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     &gt;40 kg: refer to adult dosing",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:2em;\">",
"     <b>",
"      Cystic fibrosis, pseudomonal infections (unlabeled use):",
"     </b>",
"     350-450 mg/kg/day in divided doses",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:2em;\">",
"     <b>",
"      Intra-abdominal infection, complicated:",
"     </b>",
"     200-300 mg/kg/day divided every 6-8 hours",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F210406\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F210407\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Traditional infusion method (ie, I.V. infusion over 30 minutes): Manufacturer&rsquo;s labeling:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &gt;40 mL/minute: No dosage adjustment required.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     20-40 mL/minute: Administer 2.25 g every 6 hours (3.375 g every 6 hours for nosocomial pneumonia)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;20 mL/minute: Administer 2.25 g every 8 hours (2.25 g every 6 hours for nosocomial pneumonia)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Some clinicians suggest adjusting the dose at Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &le;20 mL/minute (rather than Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;40 mL/minute) in patients receiving either traditional or extended-infusion methods, particularly if treating serious gram-negative infections (empirically or definitively) (Patel, 2010).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Extended infusion method (unlabeled dosing): Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &le;20 mL/minute: 3.375 g I.V. over 4 hours every 12 hours (Patel, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Intermittent hemodialysis (IHD)/peritoneal dialysis (PD): 2.25 g every 12 hours (2.25 g every 8 hours for nosocomial pneumonia).",
"     <b>",
"      Note:",
"     </b>",
"     Dosing dependent on the assumption of 3 times/week, complete IHD sessions. Administer scheduled doses after hemodialysis on dialysis days; if next regularly scheduled dose is not due right after dialysis session, administer an additional dose of 0.75 g after the dialysis session.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Continuous renal replacement therapy (CRRT) (Heintz, 2009; Trotman, 2005): Drug clearance is highly dependent on the method of renal replacement, filter type, and flow rate. Appropriate dosing requires close monitoring of pharmacologic response, signs of adverse reactions due to drug accumulation, as well as drug concentrations in relation to target trough (if appropriate). The following are general recommendations only (based on dialysate flow/ultrafiltration rates of 1-2 L/hour and minimal residual renal function) and should not supersede clinical judgment (Trotman, 2005):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     CVVH: 2.25-3.375 g every 6-8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     CVVHD: 2.25-3.375 g every 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     CVVHDF: 3.375 g every 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Higher dose of 3.375 g should be considered when treating resistant pathogens (especially",
"     <i>",
"      Pseudomonas",
"     </i>",
"     spp); alternative recommendations suggest dosing of 4.5 g every 8 hours (Valtonen, 2001); regardless of regimen, there is some concern of tazobactam (TAZ) accumulation, given its lower clearance relative to piperacillin (PIP). Some clinicians advocate dosing with PIP to alternate with PIP/TAZ, particularly in CVVH-dependent patients, to lessen this concern.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F210408\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment necessary.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F210378\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Note",
"     </b>",
"     : 8:1 ratio of piperacillin sodium/tazobactam sodium",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infusion [premixed iso-osmotic solution]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Zosyn&reg;: 2.25 g: Piperacillin 2 g and tazobactam 0.25 g (50 mL) [contains edetate disodium, sodium 128 mg (5.58 mEq)]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Zosyn&reg;: 3.375 g: Piperacillin 3 g and tazobactam 0.375 g (50 mL)  [contains edetate disodium, sodium 192 mg (8.38 mEq)]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Zosyn&reg;: 4.5 g: Piperacillin 4 g and tazobactam 0.5 g (100 mL) [contains edetate disodium, sodium 256 mg (11.17 mEq)]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution: 2.25 g: Piperacillin 2 g and tazobactam 0.25 g; 3.375 g: Piperacillin 3 g and tazobactam 0.375 g; 4.5 g: Piperacillin 4 g and tazobactam 0.5 g; 40.5 g: Piperacillin 36 g and tazobactam 4.5 g",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Zosyn&reg;: 2.25 g: Piperacillin 2 g and tazobactam 0.25 g [contains edetate disodium, sodium 128 mg (5.58 mEq)]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Zosyn&reg;: 3.375 g: Piperacillin 3 g and tazobactam 0.375 g [contains edetate disodium, sodium 192 mg (8.38 mEq)]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Zosyn&reg;: 4.5 g: Piperacillin 4 g and tazobactam 0.5 g [contains edetate disodium, sodium 256 mg (11.17 mEq)]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Zosyn&reg;: 40.5 g: Piperacillin 36 g and tazobactam 4.5 g [contains edetate disodium, sodium 2304 mg (100.4 mEq); bulk pharmacy vial]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F210362\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Excludes infusion",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F210382\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer by I.V. infusion over 30 minutes. For extended infusion administration (unlabeled dosing), administer over 3-4 hours (Kim 2007; Shea, 2009).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Some penicillins (eg, carbenicillin, ticarcillin, and piperacillin) have been shown to inactivate aminoglycosides",
"     <i>",
"      in vitro",
"     </i>",
"     . This has been observed to a greater extent with tobramycin and gentamicin, while amikacin has shown greater stability against inactivation. Concurrent use of these agents may pose a risk of reduced antibacterial efficacy",
"     <i>",
"      in vivo",
"     </i>",
"     , particularly in the setting of profound renal impairment. However, definitive clinical evidence is lacking. If combination penicillin/aminoglycoside therapy is desired in a patient with renal dysfunction, separation of doses (if feasible), and routine monitoring of aminoglycoside levels, CBC, and clinical response should be considered.",
"     <b>",
"      Note:",
"     </b>",
"     Reformulated Zosyn&reg; containing EDTA has been shown to be compatible",
"     <i>",
"      in vitro",
"     </i>",
"     for Y-site infusion with amikacin and gentamicin diluted in NS or D",
"     <sub>",
"      5",
"     </sub>",
"     W (applies",
"     <b>",
"      only",
"     </b>",
"     to specific concentrations and varies by product; consult manufacturer&rsquo;s labeling). Reformulated Zosyn&reg; containing EDTA is",
"     <b>",
"      not",
"     </b>",
"     compatible with tobramycin.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F210429\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     W, NS, sterile water for injection; LR (EDTA formulated product only);",
"     <b>",
"      variable stability (consult detailed reference)",
"     </b>",
"     in peritoneal dialysis solution.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Amikacin (EDTA formulated product only), aminophylline, anidulafungin (EDTA formulated product only), aztreonam, bivalirudin, bleomycin, bumetanide, buprenorphine, butorphanol, calcium gluconate, carboplatin, carmustine, cefepime, cimetidine, clindamycin, cyclophosphamide, cytarabine, dexamethasone sodium phosphate, dexmedetomidine, diphenhydramine, docetaxel, dopamine, enalaprilat, etoposide, etoposide phosphate, fenoldopam, floxuridine, fluconazole, fludarabine, fluorouracil, furosemide, gallium nitrate, gentamicin (EDTA formulated product only), granisetron, heparin, hetastarch in lactate electrolyte injection (Hextend&reg;), hydrocortisone sodium phosphate, hydrocortisone sodium succinate, hydromorphone, ifosfamide, leucovorin calcium, linezolid, lorazepam, magnesium sulfate, mannitol, meperidine, mesna, methotrexate, methylprednisolone sodium succinate, metoclopramide, metronidazole, milrinone, morphine, ondansetron, potassium chloride, ranitidine, remifentanil, sargramostim, sodium bicarbonate, telavancin (EDTA formulated product only), thiotepa, tigecycline (EDTA formulated product only), trimethoprim/sulfamethoxazole, vasopressin, vinblastine, vincristine, zidovudine.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Acyclovir, amiodarone, amphotericin B, amphotericin B cholesteryl sulfate complex, azithromycin, caspofungin (EDTA formulated product only), chlorpromazine, cisplatin, dacarbazine, daunorubicin, dobutamine, doxorubicin, doxorubicin liposome, doxycycline, droperidol, drotrecogin alfa, famotidine, ganciclovir, gemcitabine, haloperidol, hydroxyzine, idarubicin, minocycline, mitomycin, mitoxantrone, nalbuphine, pantoprazole (EDTA formulated product only), prochlorperazine edisylate, promethazine, streptozocin, tobramycin (EDTA formulated product only).",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Cisatracurium, vancomycin.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F210381\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of moderate-to-severe infections caused by susceptible organisms, including infections of the lower respiratory tract (community-acquired pneumonia, nosocomial pneumonia); uncomplicated and complicated skin and skin structures (including diabetic foot infections); gynecologic (endometritis, pelvic inflammatory disease); and intra-abdominal infections (appendicitis with rupture/abscess, peritonitis). Tazobactam expands activity of piperacillin to include beta-lactamase producing strains of",
"     <i>",
"      S. aureus",
"     </i>",
"     ,",
"     <i>",
"      H. influenzae",
"     </i>",
"     ,",
"     <i>",
"      E. coli",
"     </i>",
"     ,",
"     <i>",
"      Bacteroides",
"     </i>",
"     spp, and other gram-positive and gram-negative aerobic and anaerobic bacteria.",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F13645733\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of moderate-to-severe infections caused by susceptible organisms, including urinary tract infections, bone and joint infections, septicemia, endocarditis, and cystic fibrosis exacerbations",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F210432\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Zosyn&reg; may be confused with Zofran&reg;, Zyvox&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Tazact [India] may be confused with Tazac brand name for nizatidine [Australia]; Tiazac brand name for diltiazem [U.S., Canada]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F210422\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%: Gastrointestinal: Diarrhea (7% to 11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Hypertension (2%), chest pain (1%), edema (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Insomnia (7%), headache (8%), fever (2% to 5%), agitation (2%), pain (2%), anxiety (1% to 2%), dizziness (1% to 2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Rash (4%), pruritus (3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Constipation (1% to 8%), nausea (7%), vomiting (3% to 4%), dyspepsia (3%), stool changes (2%), abdominal pain (1% to 2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hepatic: AST increased (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Local reaction (3%), abscess (2%), phlebitis (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Pharyngitis (2%), dyspnea (1%), rhinitis (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Moniliasis (2%), sepsis (2%), infection (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1%, postmarketing, and/or case reports (Limited to important and life-threatening): Agranulocytosis, anaphylaxis/anaphylactoid reaction, anemia, anxiety, arrhythmia, arthralgia, atrial fibrillation, back pain, bradycardia, bronchospasm,",
"     <i>",
"      C. difficile",
"     </i>",
"     -associated diarrhea (CDAD), candidiasis, cardiac arrest, cardiac failure, cholestatic jaundice, circulatory failure, confusion, convulsions, coughing, depression, diaphoresis, dysuria, epistaxis, erythema multiforme, flatulence, flushing, gastritis, genital pruritus, hallucination, hematuria, hemolytic anemia, hemorrhage, hepatitis, hiccough, hypoglycemia, hypokalemia, hypotension, ileus, incontinence, inflammation, injection site reaction, interstitial nephritis, leukorrhea, malaise, melena, mesenteric embolism, myalgia, myocardial infarction, oliguria, pancytopenia, photophobia, pulmonary edema, pulmonary embolism, purpura, renal failure, rigors, Stevens-Johnson syndrome, syncope, tachycardia (supraventricular and ventricular), taste perversion, thirst, thrombocytopenia, thrombocytosis, thrombophlebitis, tinnitus, toxic epidermal necrolysis, tremor, ulcerative stomatitis, urinary retention, vaginitis, ventricular fibrillation, vertigo",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F210385\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to penicillins, cephalosporins, beta-lactamase inhibitors, or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F210366\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anaphylactoid/hypersensitivity reactions: Serious and occasionally severe or fatal hypersensitivity (anaphylactic/anaphylactoid) reactions have been reported in patients on penicillin therapy, especially with a history of beta-lactam hypersensitivity, history of sensitivity to multiple allergens, or previous IgE-mediated reactions (eg, anaphylaxis, angioedema, urticaria).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bleeding disorders: Particularly in patients with renal impairment, bleeding disorders have been observed; discontinue if thrombocytopenia or bleeding occurs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Superinfection: Use may result in fungal or bacterial superinfection, including",
"     <i>",
"      C. difficile",
"     </i>",
"     -associated diarrhea (CDAD) and pseudomembranous colitis; CDAD has been observed &gt;2 months postantibiotic treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cystic fibrosis: An increased frequency of fever and rash has been reported in patients with cystic fibrosis receiving piperacillin.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment or underdeveloped kidneys; due to sodium load and to the adverse effects of high serum concentrations of penicillins. Dosage adjustment recommended.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizure disorders: Use with caution in patients with a history of seizure disorder; high levels, particularly in the presence of renal impairment, may increase risk of seizures.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299884\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F210371\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aminoglycosides: Penicillins may decrease the serum concentration of Aminoglycosides. Primarily associated with extended spectrum penicillins, and patients with renal dysfunction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Antibiotics may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fusidic Acid: May diminish the therapeutic effect of Penicillins.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrexate: Penicillins may increase the serum concentration of Methotrexate.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mycophenolate: Penicillins may decrease serum concentrations of the active metabolite(s) of Mycophenolate. This effect appears to be the result of impaired enterohepatic recirculation.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Probenecid: May increase the serum concentration of Penicillins.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate.  Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tetracycline Derivatives: May diminish the therapeutic effect of Penicillins.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Typhoid Vaccine: Antibiotics may diminish the therapeutic effect of Typhoid Vaccine. Only the live attenuated Ty21a strain is affected.  Management: Vaccination with live attenuated typhoid vaccine (Ty21a) should be avoided in patients being treated with systemic antibacterial agents.  Use of this vaccine should be postponed until at least 24 hours after cessation of antibacterial agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Penicillins may enhance the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F210374\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F210387\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events have not been observed in animal reproduction studies. Piperacillin and tazobactam both cross the placenta and are found in the fetal serum, placenta, amniotic fluid, and fetal urine. When used during pregnancy, the clearance and volume of distribution of piperacillin/tazobactam are increased; half-life and AUC are decreased. Piperacillin/tazobactam is approved for the treatment of postpartum gynecologic infections, including endometritis or pelvic inflammatory disease, caused by susceptible organisms.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F210414\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F210388\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Low concentrations of piperacillin are excreted in breast milk; information for tazobactam is not available. The manufacturer recommends that caution be used when administering piperacillin/tazobactam to nursing women. Nondose-related effects could include modification of bowel flora. When given alone in the early postpartum period, some pharmacokinetic parameters of piperacillin may be altered (refer to Piperacillin monograph for details).",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F210389\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Some products may contain sodium.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F6856652\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Zosyn Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2-0.25 gm/50 mL (50 mL): $18.31",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     3-0.375 gm/50 mL (50 mL): $27.47",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     4-0.5 g/100 mL (100 mL): $34.81",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (Piperacillin Sod-Tazobactam So Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2-0.25 g (1): $8.40",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     3-0.375 g (1): $13.20",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     4-0.5 g (1): $17.40",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     36-4.5 g (1): $176.10",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (Zosyn Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2-0.25 g (1): $15.26",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     3-0.375 g (1): $22.90",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     4-0.5 g (1): $29.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     36-4.5 g (1): $274.87",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F210376\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Creatinine, BUN, CBC with differential, PT, PTT, serum electrolytes, LFTs, urinalysis; signs of bleeding; monitor for signs of anaphylaxis during first dose",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F210390\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Astaz-P (TH);",
"     </li>",
"     <li>",
"      Betamycin (TW);",
"     </li>",
"     <li>",
"      Co-Tazo (TW);",
"     </li>",
"     <li>",
"      Jeita (TW);",
"     </li>",
"     <li>",
"      Pipertaz (TH);",
"     </li>",
"     <li>",
"      Piptaz (PH);",
"     </li>",
"     <li>",
"      Pletzolyn (PH);",
"     </li>",
"     <li>",
"      Tabaxin (KP);",
"     </li>",
"     <li>",
"      Tasovak (MX);",
"     </li>",
"     <li>",
"      Tazobac (CH, DE);",
"     </li>",
"     <li>",
"      Tazobak (PH);",
"     </li>",
"     <li>",
"      Tazocel (ES);",
"     </li>",
"     <li>",
"      Tazocilline (FR);",
"     </li>",
"     <li>",
"      Tazocin (AE, BE, BG, BH, BR, CL, CO, CR, CY, CZ, EC, EE, EG, GB, GT, HK, HN, ID, IE, IL, IQ, IR, IT, JO, KP, KW, LB, LY, MX, MY, NI, NL, NO, OM, PA, PE, PH, PK, PL, QA, SA, SE, SG, SV, SY, TH, TR, TW, YE);",
"     </li>",
"     <li>",
"      Tazocin EF (AU, DO, NZ);",
"     </li>",
"     <li>",
"      Tazomax (UY);",
"     </li>",
"     <li>",
"      Tazonam (AR, AT, CN, PY);",
"     </li>",
"     <li>",
"      Tazopen (PH);",
"     </li>",
"     <li>",
"      Tazoperan (KP);",
"     </li>",
"     <li>",
"      Tazopip (IL);",
"     </li>",
"     <li>",
"      Tazopril (VE);",
"     </li>",
"     <li>",
"      Tazorex (IL);",
"     </li>",
"     <li>",
"      Tazpen (MY, SG);",
"     </li>",
"     <li>",
"      Tazrobida (MY, TH);",
"     </li>",
"     <li>",
"      Tebranic (TH);",
"     </li>",
"     <li>",
"      Vigocid (PH);",
"     </li>",
"     <li>",
"      Zosyn (IN)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F210365\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Piperacillin inhibits bacterial cell wall synthesis by binding to one or more of the penicillin-binding proteins (PBPs); which in turn inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls, thus inhibiting cell wall biosynthesis. Bacteria eventually lyse due to ongoing activity of cell wall autolytic enzymes (autolysins and murein hydrolases) while cell wall assembly is arrested. Piperacillin exhibits time-dependent killing. Tazobactam inhibits many beta-lactamases, including staphylococcal penicillinase and Richmond-Sykes types 2, 3, 4, and 5, including extended spectrum enzymes; it has only limited activity against class 1 beta-lactamases other than class 1C types.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F210384\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Both AUC and peak concentrations are dose proportional; hepatic impairment does not affect kinetics",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     Distribution: Well into lungs, intestinal mucosa, uterus, ovary, fallopian tube, interstitial fluid, gallbladder, and bile; penetration into CSF is low in subjects with noninflamed meninges",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: Piperacillin and tazobactam: ~30%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Piperacillin: 6% to 9% to desethyl metabolite (weak activity)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Tazobactam: ~26% to inactive metabolite",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Piperacillin: I.M.: 71%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Tazobactam: I.M.: 84%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Piperacillin and tazobactam: 0.7-1.2 hours (unaffected by dose or duration of infusion)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, plasma: Immediately following completion of 30-minute infusion",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Clearance of both piperacillin and tazobactam are directly proportional to renal function",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Piperacillin: Urine (68% as unchanged drug); feces (10% to 20%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Tazobactam: Urine (80% as unchanged drug; remainder as inactive metabolite)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dialysis: Hemodialysis removes 30% to 40% of a piperacillin/tazobactam dose; peritoneal dialysis removes 6% of piperacillin and 21% of tazobactam",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Thoracic Society and Infectious Diseases Society of America, &ldquo;Guidelines for the Management of Adults With Hospital-Acquired, Ventilator-Associated, and Healthcare-Associated Pneumonia,&rdquo;",
"      <i>",
"       Am J Respir Crit Care Med",
"      </i>",
"      , 2005, 171(4):388-416.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/15699079/pubmed\" id=\"15699079\" target=\"_blank\">",
"        15699079",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bratzler DW, Dellinger EP, Olsen KM, et al, &ldquo;Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery,&rdquo;",
"      <i>",
"       Am J Health Syst Pharm",
"      </i>",
"      , 2013, 70(3):195-283.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/23327981/pubmed\" id=\"23327981\" target=\"_blank\">",
"        23327981",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bryson HM and Brogden RN, &ldquo;Piperacillin/Tazobactam. A Review of its Antibacterial Activity, Pharmacokinetic Properties, and Therapeutic Potential,&rdquo;",
"      <i>",
"       Drugs",
"      </i>",
"      , 1994, 47(3):506-35.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/7514977/pubmed\" id=\"7514977\" target=\"_blank\">",
"        7514977",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chow MS, Quintiliani, and Nightingale CH, &ldquo;",
"      <i>",
"       In Vivo",
"      </i>",
"      Inactivation of Tobramycin by Ticarcillin. A Case Report,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 1982, 247(5):658-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/6798229/pubmed\" id=\"6798229\" target=\"_blank\">",
"        6798229",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Daly JS, Dodge RA, Glew RH, et al, &ldquo;Effect of Time and Temperature on Inactivation of Aminoglycosides by Ampicillin at Neonatal Dosages,&rdquo;",
"      <i>",
"       J Perinatol",
"      </i>",
"      , 1997, 17(1):42-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/9069064/pubmed\" id=\"9069064\" target=\"_blank\">",
"        9069064",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dowell JA, Korth-Bradley J, Milisci M, et al, &ldquo;Evaluating Possible Pharmacokinetic Interactions Between Tobramycin, Piperacillin, and a Combination of Piperacillin and Tazobactam in Patients With Various Degrees of Renal Impairment,&rdquo;",
"      <i>",
"       J Clin Pharmacol",
"      </i>",
"      , 2001, 41:979-86.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/11549103/pubmed\" id=\"11549103\" target=\"_blank\">",
"        11549103",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Farchione LA, \"Inactivation of Aminoglycosides by Penicillins,&rdquo;",
"      <i>",
"       J Antimicrob Chemother",
"      </i>",
"      , 1982, 8(Suppl A):27-36.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Fuchs PC, Stickel S, Anderson PH, et al, &ldquo;",
"      <i>",
"       In Vitro",
"      </i>",
"      Inactivation of Aminoglycosides by Sulbactam, Other Beta-Lactams, and Sulbactam-Beta-Lactam Combinations,&rdquo;",
"      <i>",
"       Antimicrob Agents Chemother",
"      </i>",
"      , 1991, 35(1):182-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/2014975/pubmed\" id=\"2014975\" target=\"_blank\">",
"        2014975",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Halstenson CE, Wong MO, Herman CS, et al, &ldquo;Effect of Concomitant Administration of Piperacillin on the Dispositions on Isepamicin and Gentamicin in Patients With End-Stage Renal Disease,&rdquo;",
"      <i>",
"       Antimicrob Agents Chemother",
"      </i>",
"      , 1992, 36(9):1832-36.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/1416875/pubmed\" id=\"1416875\" target=\"_blank\">",
"        1416875",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Heintz BH, Matzke GR, Dager WE, &ldquo;Antimicrobial Dosing Concepts and Recommendations for Critically Ill Adult Patients Receiving Continuous Renal Replacement Therapy or Intermittent Hemodialysis,&rdquo;",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 2009, 29(5):562-77.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/19397464/pubmed\" id=\"19397464\" target=\"_blank\">",
"        19397464",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hitt CM, Patel KB, Nicolau DP, et al, &ldquo;Influence of Piperacillin-Tazobactam on Pharmacokinetics of Gentamicin Given Once Daily,&rdquo;",
"      <i>",
"       Am J Health Syst Pharm",
"      </i>",
"      , 1997, 54(23):2704-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/9408514/pubmed\" id=\"9408514\" target=\"_blank\">",
"        9408514",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kim A, Sutherland CA, Kuti JL, et al, &ldquo;Optimal Dosing of Piperacillin-Tazobactam for the Treatment of",
"      <i>",
"       Pseudomonas aeruginosa",
"      </i>",
"      Infections: Prolonged or Continuous infusion,&rdquo;",
"      <i>",
"       Pharmacother",
"      </i>",
"      , 2007, 27(11):1490-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/17963458/pubmed\" id=\"17963458\" target=\"_blank\">",
"        17963458",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kim M-K, Capitano B, Mattoes HM, et al, &ldquo;Pharmacokinetic and Pharmacodynamic Evaluation of Two Dosing Regimens for Piperacillin-Tazobactam,&rdquo;",
"      <i>",
"       Pharmacother",
"      </i>",
"      , 2002, 22(5):569-77.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Konishi H, Goto M, Nakamoto Y, et al, &ldquo;Tobramycin Inactivation by Carbenicillin, Ticarcillin, and Piperacillin,&rdquo;",
"      <i>",
"       Antimicrob Agents Chemother",
"      </i>",
"      , 1983, 23(5):653-57.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/6223576/pubmed\" id=\"6223576\" target=\"_blank\">",
"        6223576",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lambourne J, Kitchen J, Hughes C, et al, &ldquo;Piperacillin/Tazobactam-Induced Paresthesiae,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 2006, 40(5):977-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/16622157/pubmed\" id=\"16622157\" target=\"_blank\">",
"        16622157",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lau A, Lee M, Flascha S, et al, &ldquo;Effect of Piperacillin on Tobramycin Pharmacokinetics in Patients with Normal Renal Function,&rdquo;",
"      <i>",
"       Antimicrob Agents Chemother",
"      </i>",
"      , 1983, 24(4):533-37.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/6651279/pubmed\" id=\"6651279\" target=\"_blank\">",
"        6651279",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lipsky BA, Berendt AR, Cornia PB, et al, \"2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infections,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2012, 54(12):e132-73.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/22619242/pubmed\" id=\"22619242\" target=\"_blank\">",
"        22619242",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mandell LA, Wunderink RG, Anzueto A, et al, \"Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2007, 44(Suppl 2):27-72.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/17278083/pubmed\" id=\"17278083\" target=\"_blank\">",
"        17278083",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      <i>",
"       Nelson Textbook of Pediatrics",
"      </i>",
"      , 17th ed, Behrman RE, Kliegman RM, and Jenson HB, eds, Philadelphia, PA: WB Saunders Co, 2004.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Patel N, Scheetz MH, Drusano GL, et al, \"Identification of Optimal Renal Dosage Adjustments for Traditional and Extended-Infusion Piperacillin-Tazobactam Dosing Regimens in Hospitalized Patients,\"",
"      <i>",
"       Antimicrob Agents Chemother",
"      </i>",
"      , 2010, 54(1):460-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/19858253/pubmed\" id=\"19858253\" target=\"_blank\">",
"        19858253",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Perez-Vazquez A, Pastor JM, and Riancho JA, &ldquo;Immune Thrombocytopenia Caused by Piperacillin/Tazobactam,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 1998, 27(3):650-1.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/9770174/pubmed\" id=\"9770174\" target=\"_blank\">",
"        9770174",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Reed MD, &ldquo;The Pathophysiology and Treatment of Cystic Fibrosis,&rdquo;",
"      <i>",
"       J Pediatr Pharm Pract",
"      </i>",
"      , 1997, 2:285&ndash;305.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Reichardt P, Handrick W, Linke A, et al, &ldquo;Leukocytopenia, Thrombocytopenia and Fever Related to Piperacillin/Tazobactam Treatment &minus; a Retrospective Analysis in 38 Children With Cystic Fibrosis,&rdquo;",
"      <i>",
"       Infection",
"      </i>",
"      , 1999, 27(6):355-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/10624596/pubmed\" id=\"10624596\" target=\"_blank\">",
"        10624596",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Russoe ME and Atkins-Thor E, &ldquo;Gentamicin and Ticarcillin in Subjects With End-Stage Renal Disease. Comparison of Two Assay Methods and Evaluation of Inactivation Rate,&rdquo;",
"      <i>",
"       Clin Nephrol",
"      </i>",
"      , 1981, 15(4):175-80.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/7237864/pubmed\" id=\"7237864\" target=\"_blank\">",
"        7237864",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sanders WE Jr and Sanders CC, &ldquo;Piperacillin/Tazobactam: A Critical Review of the Evolving Clinical Literature,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 1996, 22(1):107-23.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/8824974/pubmed\" id=\"8824974\" target=\"_blank\">",
"        8824974",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Schoonover LL, Occhipinti DJ, Rodvold KA, et al, &ldquo;Piperacillin/Tazobactam: A New Beta-Lactam/Beta-Lactamase Inhibitor Combination,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 1995, 29(5):501-14.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/7655135/pubmed\" id=\"7655135\" target=\"_blank\">",
"        7655135",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Shea KM, Cheatham SC, Smith DW, et al, &ldquo;Comparative Pharmacodynamics of Intermittent and Prolonged Infusions of Piperacillin/Tazobactam Using Monte Carlo Simulations and Steady-State Pharmacokinetic Data from Hospitalized Patients,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 2009, 43(11):1747-54.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/19809009/pubmed\" id=\"19809009\" target=\"_blank\">",
"        19809009",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Solomkin JS, Mazuski JE, Bradley JS, et al, &ldquo;Diagnosis and Management of Complicated Intra-Abdominal Infections in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      ,  2010, 50(2):133-64.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/20034345/pubmed\" id=\"20034345\" target=\"_blank\">",
"        20034345",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sorgel F and Kinzig M, &ldquo;The Chemistry, Pharmacokinetics and Tissue Distribution of Piperacillin/Tazobactam,&rdquo;",
"      <i>",
"       J Antimicrob Chemother",
"      </i>",
"      , 1993, 31(Suppl A):39-60.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Stevens DL, Bisno AL, Chambers HF, et al, \"Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2005, 41(10):1373-406.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/16231249/pubmed\" id=\"16231249\" target=\"_blank\">",
"        16231249",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      <i>",
"       Teddy Bear Book: Pediatric Injectable Drugs",
"      </i>",
"      , 7th ed, Phelps SJ and Hak EB, eds, Bethesda, MD: American Society of Health-System Pharmacists, 2003.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Thompson MIB, Russo ME, Saxon BJ, et al, &ldquo;Gentamicin Inactivation by Piperacillin or Carbenicillin in Patients With End-Stage Renal Disease,&rdquo;",
"      <i>",
"       Antimicrob Agents Chemother",
"      </i>",
"      , 1982, 21(2):268-73.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/6462107/pubmed\" id=\"6462107\" target=\"_blank\">",
"        6462107",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Trotman RL, Williamson JC, Shoemaker DM, et al,&ldquo;Antibiotic Dosing in Critically Ill Adult Patients Receiving Continuous Renal Replacement Therapy,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2005, 41(8):1159-66.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/16163635/pubmed\" id=\"16163635\" target=\"_blank\">",
"        16163635",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Valtonen M, Tiula E, Takkunen O, et al, &ldquo;Elimination of the Piperacillin/Tazobactam Combination During Continuous Venovenous Haemofiltration and Haemodiafiltration in Patients With Acute Renal Failure,&rdquo;",
"      <i>",
"       J Antimicrob Chemother",
"      </i>",
"      , 2001, 48(6):881-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/11733473/pubmed\" id=\"11733473\" target=\"_blank\">",
"        11733473",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      van der Werf TS, Mulder PO, Zijlstra JG, et al, &ldquo;Pharmacokinetics of Piperacillin and Tazobactam in Critically Ill Patients With Renal Failure, Treated With Continuous Veno-Venous Hemofiltration (CVVH),\"",
"      <i>",
"       Intensive Care Med",
"      </i>",
"      , 1997, 23(8):873-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/9310805/pubmed\" id=\"9310805\" target=\"_blank\">",
"        9310805",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Viollier AF, Standiford HC, Drusano GL, et al, &ldquo;Comparative Pharmacokinetics and Serum Bactericidal Activity of Mezlocillin, Ticarcillin and Piperacillin, With and Without Gentamicin,&rdquo;",
"      <i>",
"       J Antimicrob Chemother",
"      </i>",
"      , 1985, 15(5):597-606.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/4008387/pubmed\" id=\"4008387\" target=\"_blank\">",
"        4008387",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Walterspiel JN, Feldman S, Van R, et al, &ldquo;Comparative Inactivation of Isepamicin, Amikacin, and Gentamicin by Nine Beta-Lactams and Two Beta-Lactamase Inhibitors, Cilastatin and Heparin,&rdquo;",
"      <i>",
"       Antimicrob Agents Chemother",
"      </i>",
"      , 1991, 35(9):1875-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/1952861/pubmed\" id=\"1952861\" target=\"_blank\">",
"        1952861",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Yamagishi Y, Terada M, Ohki E, et al, \"Investigation of the Clinical Breakpoints of Piperacillin-Tazobactam Against Infections Caused by",
"      <i>",
"       Pseudomonas aeruginosa",
"      </i>",
"      ,\"",
"      <i>",
"       J Infect Chemother",
"      </i>",
"      , 2011.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/21814800/pubmed\" id=\"21814800\" target=\"_blank\">",
"        21814800",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Zaki SA and Lad V, \"Piperacillin-Tazobactam-Induced Hypokalemia and Metabolic Alkalosis,\"",
"      <i>",
"       Indian J Pharmacol",
"      </i>",
"      , 2011, 43(5):609-10.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/41/24216/abstract-text/22022014/pubmed\" id=\"22022014\" target=\"_blank\">",
"        22022014",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9777 Version 42.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-217.117.136.88-59DAAF2E3B-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_41_24216=[""].join("\n");
var outline_f23_41_24216=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210401\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210402\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210424\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210405\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210418\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210406\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210407\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210408\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210378\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210362\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210382\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210429\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210381\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13645733\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210432\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210422\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210385\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210366\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299884\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210371\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210374\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210387\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210414\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210388\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210389\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6856652\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210376\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210390\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210365\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210384\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9777\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9777|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?39/20/40259?source=related_link\">",
"      Piperacillin and tazobactam sodium: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?27/27/28086?source=related_link\">",
"      Piperacillin and tazobactam sodium: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_41_24217="Keloid ear lobe";
var content_f23_41_24217=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F54044%7EDERM%2F61382&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F54044%7EDERM%2F61382&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Keloid",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A large keloid of the ear lobe.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Keloids from acne",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 315px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Stedman's Medical Dictionary. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_41_24217=[""].join("\n");
var outline_f23_41_24217=null;
var title_f23_41_24218="Facial nerve anatomy";
var content_f23_41_24218=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F55677&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F55677&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 557px\">",
"   <div class=\"ttl\">",
"    Cranial nerve VII (facial nerve) anatomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 537px; height: 790px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The facial nerve provides motor innervation to all the muscles of facial expression and the three muscle derivatives of the second pharyngeal arch (posterior digastric, stapedius, and stylohyoid). It parasympathetically fires three of the four glands in the head: the submandibular and sublingual salivary glands, and the lacrimal gland (A). Other parasympathetic fibers stimulate mucous secretion in the nose and palate. Taste fibers from the anterior two-thirds of the tongue follow the path of the lingual branch of cranial nerve (CN) V until just before entering the cranium as a distinct chorda tympani nerve (B).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Moore, KL, Agur, AMR. Essential Clinical Anatomy, 2nd Edition. Baltimore, Lippincott Williams &amp; Wilkins, 2002. Copyright &copy; 2002 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_41_24218=[""].join("\n");
var outline_f23_41_24218=null;
var title_f23_41_24219="Diagnosis of acute scrotal pain";
var content_f23_41_24219=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F56026&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F56026&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Distinguishing conditions responsible for acute scrotal pain in adults",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Symptom onset",
"       </td>",
"       <td class=\"subtitle1\">",
"        Pain location",
"       </td>",
"       <td class=\"subtitle1\">",
"        Cremasteric reflex",
"       </td>",
"       <td class=\"subtitle1\">",
"        Other clinical findings",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Testicular torsion",
"       </td>",
"       <td>",
"        Acute",
"       </td>",
"       <td>",
"        Testis",
"       </td>",
"       <td>",
"        Negative",
"       </td>",
"       <td>",
"        High riding testis, bell-clapper deformity, profound testicular swelling",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Epididymitis",
"       </td>",
"       <td>",
"        Acute or chronic",
"       </td>",
"       <td>",
"        Epidiymis",
"       </td>",
"       <td>",
"        Positive",
"       </td>",
"       <td>",
"        Epididymal induration and tenderness, positive urinalysis or culture",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fournier's gangrene",
"       </td>",
"       <td>",
"        Acute",
"       </td>",
"       <td>",
"        Diffuse",
"       </td>",
"       <td>",
"        Positive",
"       </td>",
"       <td>",
"        Tense edema outside of involved skin, blisters/bullae, crepitus, fever, rigors, hypotension",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Appendiceal torsion",
"       </td>",
"       <td>",
"        Subacute",
"       </td>",
"       <td>",
"        Upper pole of testis",
"       </td>",
"       <td>",
"        Positive",
"       </td>",
"       <td>",
"        Blue dot sign, tenderness over anterosuperior testis",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_41_24219=[""].join("\n");
var outline_f23_41_24219=null;
var title_f23_41_24220="DMD post anesthesia";
var content_f23_41_24220=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F67162&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F67162&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Summary of the American College of Chest Physicians (ACCP) consensus statement suggestions for the management of patients with Duchenne muscular dystrophy (DMD) after general anesthesia or procedural sedation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Consider extubating patients with DMD who have a forced vital capacity (FVC) &lt;50 percent of predicted, and especially those with FVC &lt;30 percent of predicted, directly to noninvasive positive pressure ventilation (NPPV)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &bull; Consider delaying extubation until respiratory secretions are well controlled and oxyhemoglobin saturation measured by pulse oximetry (SpO2) is normal or baseline in room air; continuous use of NPPV can then be weaned as tolerated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &bull; When applicable, try to utilize the patient's home interface after extubation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Use supplemental oxygen therapy cautiously",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &bull; Monitor SpO2 continuously after general anesthesia or procedural sedation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &bull; Whenever possible, monitor blood or end-tidal carbon dioxide levels",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &bull; Assess if hypoxemia is due to hypoventilation, atelectasis, or airway secretions, and treat appropriately",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Use manually assisted cough and postoperatively in patients with DMD who have impaired cough, defined in adults as peak cough flow (PCF) &lt;270 L/min or maximum expiratory pressure (MEP) &lt;60 cmH2O",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Optimize postoperative pain control in patients with DMD",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &bull; If sedation and/or hypoventilation occurs, delay endotracheal extubation for 24 to 48 hours or use NPPV",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Obtain a cardiology consultation and closely monitor cardiac and fluid status postoperatively",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Initiate bowel regimens to avoid and treat constipation and consider prokinetic GI medications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &bull; Consider gastric decompression with a nasogastric tube in patients with GI dysmotility",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &bull; Start parenteral nutrition or enteral feeding via a small-diameter tube if oral feeding is delayed for &gt;24 to 48 hours postoperatively",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Birnkrant, DJ, Panitch, HB, Benditt, JO, et al. American College of Chest Physicians consensus statement on the respiratory and related management of patients with Duchenne muscular dystrophy undergoing anesthesia or sedation. Chest 2007; 132:1977.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_41_24220=[""].join("\n");
var outline_f23_41_24220=null;
var title_f23_41_24221="Drug monitoring CMV retinitis";
var content_f23_41_24221=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F80535&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F80535&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Drug regimens and monitoring in the treatment of cytomegalovirus retinitis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Drug",
"      </td>",
"      <td class=\"subtitle1\">",
"       Induction regimen",
"      </td>",
"      <td class=\"subtitle1\">",
"       Maintenance regimen",
"      </td>",
"      <td class=\"subtitle1\">",
"       Laboratory tests",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"4\" rowspan=\"1\">",
"       Ganciclovir",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2_start\" colspan=\"3\" rowspan=\"1\">",
"       Intravenous*",
"      </td>",
"      <td colspan=\"1\" rowspan=\"3\">",
"       Complete blood count (CBC) twice/week during induction, weekly during maintenance; serum creatinine monthly",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       Standard dose",
"      </td>",
"      <td class=\"sublist_other\">",
"       5 mg/kg every 12 hr for 14 days",
"      </td>",
"      <td class=\"sublist_other\">",
"       5 mg/kg/day",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       High dose",
"      </td>",
"      <td class=\"sublist_other\">",
"       5-7.5 mg/kg every 12 hr for 14 days",
"      </td>",
"      <td class=\"sublist_other\">",
"       10 mg/kg/day",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Oral valganciclovir&bull;",
"      </td>",
"      <td>",
"       900 mg every 12 h for 21 days",
"      </td>",
"      <td>",
"       900 mg/day",
"      </td>",
"      <td>",
"       Same as above",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Implant",
"      </td>",
"      <td>",
"       Surgical placement",
"      </td>",
"      <td>",
"       Replacement after 6 months",
"      </td>",
"      <td>",
"       Not applicable",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Intravitreal injection",
"      </td>",
"      <td>",
"       400 &micro;g twice/week",
"      </td>",
"      <td>",
"       400 &micro;g/week",
"      </td>",
"      <td>",
"       Not applicable",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"4\" rowspan=\"1\">",
"       Foscarnet",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Standard dose&Delta;",
"      </td>",
"      <td>",
"       90 mg/kg every 12 hr for 14 days",
"      </td>",
"      <td>",
"       90 mg/kg/day",
"      </td>",
"      <td>",
"       Serum creatinine, potassium, magnesium, calcium and phosphorous twice/week during induction, weekly during maintenance; hemoglobin",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       High dose&Delta;",
"      </td>",
"      <td>",
"       90 mg/kg every 12 hr for 14 days",
"      </td>",
"      <td>",
"       120 mg/kg/day",
"      </td>",
"      <td>",
"       Same as for standard dose foscarnet",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Intravitreal injection",
"      </td>",
"      <td>",
"       2400 &micro;g twice/week",
"      </td>",
"      <td>",
"       2400 &micro;g/week",
"      </td>",
"      <td>",
"       Not applicable",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"1\" rowspan=\"2\">",
"       Ganciclovir* and foscarnet&Delta;",
"      </td>",
"      <td>",
"       90 mg foscarnet/kg every 12 hr plus 5 mg ganciclovir/kg/day for 14 days",
"       <strong>",
"        OR",
"       </strong>",
"      </td>",
"      <td colspan=\"1\" rowspan=\"2\">",
"       5 mg ganciclovir/kg/day plus 90 mg foscarnet/kg/day",
"      </td>",
"      <td colspan=\"1\" rowspan=\"2\">",
"       Same as for intravenous ganciclovir alone or intravenous foscarnet alone",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       5 mg ganciclovir/kg/12 hr plus 90 mg foscarnet/kg/day for 14 days",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\">",
"       Cidofovir&loz;",
"      </td>",
"      <td>",
"       5 mg/kg/week for 2 weeks",
"      </td>",
"      <td>",
"       5 mg/kg every 2 weeks",
"      </td>",
"      <td>",
"       Serum creatinine, urinary protein and CBC before each infusion",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * The drug is given as a one-hour infusion. Dose should be reduced if estimated creatinine clearance &lt;70 mL/min (see package insert for details).",
"     <br>",
"      &bull; Dose should be reduced if estimated creatinine clearance &lt;60-70 mL/min (see package insert for details).",
"      <br>",
"       &Delta; Foscarnet is given as a two-hour intravenous infusion administered by pump to control the rate; dilute to 12 mg/mL with 5 percent dextrose or normal saline if administered through a peripheral vein (to prevent thrombophlebitis). Foscarnet should not be mixed with any other drug or supplement. Dose must be reduced if estimated creatinine clearance is &lt;1.4 ml/min/kg (see package insert for details). Hydration may reduce the risk of nephrotoxicity. It is recommended that 750-1000 mL of normal saline or 5 percent dextrose solution should be given prior to the first infusion of foscarnet to establish diuresis. With subsequent infusions, 750-1000 mL of hydration fluid should be given with 90-120 mg/kg of foscarnet. Hydration fluid may need to be decreased if clinically warranted. After the first dose, the hydration fluid should be administered concurrently with each infusion of foscarnet.",
"       <br>",
"        &loz;Given as a 1-hour IV infusion. Administer 2 g probenecid orally 3 hrs before infusion and 1 L normal saline 1 hr before infusion. Administer 1 L normal saline with cidofovir. Administer 1 g probenecid orally 2 and 8 hrs after infusion has been completed. Cidofovir is contraindicated if baseline urinary protein level is &ge;2+, serum creatinine level is &gt;1.5 mg/dL, or (133 &micro;mol/L) estimated creatinine clearance is &le;55 mL/min. Dose should be reduced from 5 to 3 mg/kg if serum creatinine level increases by 0.3 to 0.4 mg/dL over baseline value. Drug must be discontinued if serum creatinine level increases by &gt;0.5 mg/dL (44 &micro;mol/L) over baseline value or if urinary protein level is &gt;3+. Cidofovir should not be administered concurrently with or within 7 days of other nephrotoxic drugs (eg, foscarnet, aminoglycosides, amphotericin B, nonsteroidal antiinflammatory drugs, or parenteral pentamidine).",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Jacobson, MA, N Engl J Med 1997; 337:105.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_41_24221=[""].join("\n");
var outline_f23_41_24221=null;
var title_f23_41_24222="Interphase FISH";
var content_f23_41_24222=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F60540&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F60540&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Interphase FISH",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 433px; height: 300px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Interphase fluorescence in situ hybridization (FISH) is a modification of FISH analysis that allows high resolution analysis because probes are hybridized to minimally condensed interphase chromosomes. In the interphase nucleus, chromosomal structures cannot be discerned and only the hybridized probe will light up. The cell nucleus in this figure was hybridized with a probe for a region on the X chromosome (red) and one for an area on the Y chromosome (green). The presence of three separate signals indicates that this individual has two X chromosomes (red) and one Y chromosome (green). This chromosomal abnormality causes Klinefelter syndrome.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_41_24222=[""].join("\n");
var outline_f23_41_24222=null;
var title_f23_41_24223="Traumatized airway management algorithm";
var content_f23_41_24223=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F75200&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F75200&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 566px\">",
"   <div class=\"ttl\">",
"    Algorithm for management of traumatized airway",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 546px; height: 579px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     RSI: rapid sequence intubation; SaO",
"     <sub>",
"      2",
"     </sub>",
"     : arterial oxygen saturation; TTJV: transtracheal jet ventilation.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_41_24223=[""].join("\n");
var outline_f23_41_24223=null;
